What is a universal cannabis symbol?

A universal cannabis symbol is a state-mandated graphic that must appear on cannabis product packaging to identify that the product contains THC. Each state designs its own — for example, California uses a black triangle with a cannabis leaf and the letters 'CA', while Colorado uses a red diamond with an exclamation point and 'THC'. Most states set a minimum size (commonly 0.5" × 0.5") and require placement on the principal display panel.

Do all states require child-resistant cannabis packaging?

Nearly all regulated U.S. cannabis markets require child-resistant (CR) packaging that meets federal 16 CFR 1700 / Poison Prevention Packaging Act standards. Several states add extra requirements: resealable CR for multi-serving products, opaque packaging, minimum material thickness, or third-party CR certification documentation.

Which states require packaging pre-approval before sale?

As of June 2026, thirteen markets require regulator review of packaging or labels before products can be sold, including Missouri, Nevada, Oregon, Washington, Montana, Pennsylvania, West Virginia, and North Dakota. Review timelines range from days to over 60 days, so build approval into your production schedule.

What are typical THC limits per serving and per package for edibles?

Most adult-use states cap edibles at 10 mg THC per serving and 100 mg per package (California, Colorado, Nevada, Washington, Illinois, New Mexico). Some are stricter — Massachusetts and Montana use 5 mg servings, and Virginia's upcoming market caps packages at 50 mg. Medical-only programs vary widely.

Can I use the same cannabis packaging in multiple states?

Rarely without modification. Symbol artwork, warning text, font minimums, and placement rules differ by state — and some states (New Jersey, Florida, Missouri) restrict colors or imagery entirely. Multi-state operators typically design a base dieline and swap a state-specific compliance layer per market.

How current is the information on this page?

The Royal Supply compliance team verifies this reference against state regulations and official agency sources monthly. This page was last verified in August 31, 2026. It is reference material only — always confirm with your state regulator and legal counsel.

Does Royal Supply produce state-compliant packaging?

Yes. Royal Supply designs and manufactures cannabis packaging — bags, jars, boxes, vape hardware and more — with state compliance built in from the start, including symbol placement, warning panels, and child-resistant certification. Request a quote at royalsupplywholesale.com.

Cannabis Packaging Compliance by State

State-By-State
Packaging Compliance
Made Simple

Universal symbols, required warning statements, child-resistant packaging rules, and design specs for every regulated U.S. cannabis market — researched, verified, and kept current by the Royal Supply compliance team.

40State Guides

24Adult-Use Markets

16Medical Markets

August 31, 2026Last Verified

Where We Keep You Compliant

The U.S. Cannabis Coverage Map

Hover any state for a snapshot. Click a colored state to open its full packaging & labeling guide.

Adult-Use · 23 Medical Only · 16 Launching Soon · 1 No Program · 10

🌎

Loading map…

Requires an internet connection to draw state boundaries.

Every Market, One Place

State Packaging & Labeling Guides

Symbol specs, verbatim government warnings, child-resistant packaging rules, and official artwork downloads for all 40 regulated markets.

Symbol previews are representative recreations — official artwork is linked inside each guide.

Self-Serve Audit

Packaging Label Checker Beta

An automated first-pass review of your dieline against state requirements. This tool is in active development — treat every result as a starting point for review with your compliance and legal team, never as a final verdict.

⚖️ Beta — reference tool only. Automated checks can miss requirements or flag false positives. Always confirm final packaging with your state regulator and your compliance / legal counsel before production.

Side By Side

Compare State Requirements

Selling in multiple states? Scan THC limits, symbol sizes, font minimums, materials, and child-resistance standards across every market at once.

State	Market	Max THC / Serving	Max THC / Package	Symbol Min Size	Min Font	Pre-Approval	Opaque Required	Sustainability	Plastic Ban
Alaska	Adult-Use & Medical	Not specified	Not specified	Not mandated	Not specified	No	Yes	No	No
Arizona	Adult-Use & Medical	Not specified	Not specified	QR: 1"×1"	Not specified	No	Opaque or translucent	No	No
California	Adult-Use & Medical	10 mg	100 mg	0.5" tall (height only)	6 pt	No	Yes (edibles)	No	No
Colorado	Adult-Use & Medical	10 mg	100 mg	0.5"×0.5"	1/16"	No	Yes	No	No
Connecticut	Adult-Use & Medical	5 mg (edible)	100 mg (multi-serving edible)	0.5"×0.5" (each of two symbols)	1/10" (cap K)	No	Yes — one uniform colour	No	No
Delaware	Adult-Use & Medical	10 mg	100 mg edible / 60 mg beverage / 500 mg tincture	0.5"×0.5"	6 pt or 1/2"	No	Yes	No	No
Illinois	Adult-Use & Medical	10 mg	100 mg	Not specified	Not specified	No	Yes	No	No
Maine	Adult-Use & Medical	10 mg	200 mg	0.5"×0.5"	6 pt	No	Yes	No	No
Maryland	Adult-Use & Medical	Not specified	Not specified	Must be visible	Not specified	No	Yes	No	No
Massachusetts	Adult-Use & Medical	5 mg	100 mg	0.5"×0.5"	Not specified	No	Opaque or translucent	No	No
Michigan	Adult-Use & Medical	Not specified	Not specified	0.75"×0.75"	Not specified	No	Yes	No	No
Minnesota	Adult-Use & Medical	Not specified	Not specified	0.5"×0.5" IICPS; 0.75"×0.6" warning symbol	6 pt	No	Yes	No	No
Missouri	Adult-Use & Medical	Not specified	Not specified	Must be legible	7 pt	Yes — DHSS	Yes	No	No
Montana	Adult-Use & Medical	5 mg	100 mg	0.33"×0.33"	Not specified	Yes — DoR	Yes	No	No
Nevada	Adult-Use & Medical	10 mg	100 mg	Must be visible	Not specified	Yes — CCB	Yes	No	No
New Jersey	Adult-Use & Medical	Not specified	Not specified	Must be visible	6 pt / 10 pt	No	Yes (single color)	Biodegradable effort	No
New Mexico	Adult-Use & Medical	10 mg	100 mg	0.5"×0.5"	1/16"	No	Yes	Compostable/recyclable	No
New York	Adult-Use & Medical	Not specified	Not specified	1.25"×1.25"	6 pt	No	Allowed w/ light protection	25% recycled plastic	No
Ohio	Adult-Use & Medical	500 mg (non-med) / 10 mg (med)	1,500 mg (non-med) / 110 mg (med)	0.25"×0.25"	Not specified	No	Yes	No	No
Oregon	Adult-Use & Medical	Not specified	Not specified	0.48"×0.35"	1/16"	Yes — OLCC	Must not appeal to minors	EPR fees due July 2026	No
Rhode Island	Adult-Use & Medical	Not specified	Not specified	1"×1" (vape cart 0.25"×0.25")	8 pt bold	No	Tamper-evident	No	No
Vermont	Adult-Use & Medical	Not specified	Not specified	0.5"×0.5" each of two symbols	10 pt bold (short statements)	No	Yes	No	Yes — retail plastic banned
Virginia	Adult-Use (Regs due 9/1/26 — not published; Sales 7/1/27)	10 mg	100 mg	TBD	Not specified	TBD	Yes	No	No
Washington	Adult-Use & Medical	10 mg	100 mg	0.75"×0.75"	Not specified	Yes — LCB	Yes	No	No
Alabama	Medical Only (Sales begin May 4, 2026)	Not specified	Not specified	Conspicuous	Not specified	No	Not mandated	No	No
Arkansas	Medical Only	Not specified	Not specified	0.48"×0.35"	8 pt (18 pt on two)	No	No — no opacity rule	No	No
Florida	Medical Only	Not specified	Not specified	Must be visible	6 pt	No	Yes (single solid color)	No	No
Georgia	Medical Only (Expanded — SB 220 Signed 5/12/26)	12,000 mg patient possession	Pharma container	Pharma label	Pharma label	No	Standard pharma	No	No
Hawaii	Medical Only	10 mg/capsule	1,000 mg	Must be visible	Not specified	No	Yes	No	No
Iowa	Medical Only (Ltd.)	Not specified	Not specified	Conspicuous	Not specified	No	Implied	No	No
Kentucky	Medical Only	Not specified	Not specified	Conspicuous	1/16"	No	Yes	No	No
Louisiana	Medical Only	Not specified	Not specified	No state symbol	Not specified	No	Light-impermeable at issue	No	No
Mississippi	Medical Only	Not specified	Not specified	Must be visible	Not specified	No	Yes	No	No
New Hampshire	Medical Only	Not specified	Not specified	ATC logo only	Not specified	No	Yes	No	No
North Dakota	Medical Only	5 mg (lozenges)	50 mg (lozenges)	Must be visible	8 pt	Yes — NDHHS	Yes	No	No
Oklahoma	Medical Only	Not specified	Not specified	Must be visible	Not specified	No	Yes (except clear flower)	No	No
Pennsylvania	Medical Only	Not specified	Not specified	No symbol required	Not specified	Yes — DoH	Yes — dry leaf exempt	No	No
South Dakota	Medical Only	10 mg (beverages)	100 mg (bev.)	Must be visible	Not specified	No	Yes	No	No
Utah	Medical Only	Not specified	Not specified	No size set by rule	1/16" lowercase o	Yes — UDAF	No — no opacity rule	No	No
West Virginia	Medical Only	Not specified	Not specified	Conspicuous	Not specified	Yes — BPH	Yes	No	No

State	Required Fonts	Font Minimum	Symbol Colors	CMYK / PMS	Symbol Placement	Bold Required	Notes
Alaska	Not specified	Not specified	Not specified	Not specified	Conspicuous location on label	No	THC/potency profile disclosure required in any legible font.
Arizona	Not specified	Not specified	Not specified	Not specified	Principal display panel or front; QR code 1"×1" min	No	QR code must be scannable; test on final print stock.
California	Not specified	Not specified	Black (K:100)	K: 100% (black symbol)	Primary display panel, front facing	Yes (warning text)	Warning text must be in bold capital letters. Symbol must be black.
Colorado	Not specified	1/16" min	PMS 485 / Black / White	C:0 M:100 Y:100 K:0 / K:100 / K:0	Front of container AND on any marketing layer; each individual edible serving	Below symbol only	Required text no smaller than 1/16". Symbol: red diamond, black leaf/text.
Connecticut	Times New Roman (mandatory)	1/10" min, measured on a capital "K"	As issued by DCP	As issued by DCP	Unobscured; two symbols at 0.5"×0.5" min, three on medical	No — flat regular typeface required	Label copy must be black Times New Roman, flat regular typeface, on a contrasting background. Packaging entirely and uniformly one colour; edible packaging and edible labels entirely and uniformly white. Logo max three colours and 1"×1", black only on edibles. Primary warning must be outlined by a red box; one of four health warnings rotates quarterly.
Delaware	Not specified	6 pt or 1/2"	As issued by the Commissioner	As issued by the Commissioner	Front or most prominently displayed area of the marketing layer; 0.5"×0.5" min	No	Symbol must contrast sufficiently with the background and must remain in the form the Commissioner provides — no modifying, recreating, stylizing, distorting or resizing that changes its appearance. Minimum type size of 6 point (or 1/2 inch) is codified and applies to every label element, not just warnings.
Illinois	Not specified	Not specified	Not specified	Not specified	Prominently on front panel	No	Marketing layer packaging cannot exceed 5"×5".
Maine	Not specified	6 pt / 1-12 in min; closure and sample notices 12 pt	Department black and red on white	As published by the Department — no PMS or CMYK build is set by rule	Front/most predominantly displayed area of marketing layer; 0.5"×0.5" min	Yes (closure and consumer sample notices, in capitals)	White background with white interior required. Each standardized edible serving is marked unless impracticable: 0.25"×0.25" min, or 25% of the serving width if the symbol is centred horizontally and 25% of its height if centred vertically. Individual serving wrappers and blister lidding must be white and may carry the symbol as their only image — no branding at serving level. Symbol may not be modified, stylized, stretched or distorted.
Maryland	Not specified	Not specified	Not specified	Not specified	Front of packaging	No	QR code linking to Certificate of Analysis required on all labels as of Jan 1, 2024.
Massachusetts	Not specified	Not specified	As issued by CCC	As issued by CCC	Prominently on primary panel	No	Two symbols required: cannabis identifier + harm-to-children symbol. Both from CCC.
Michigan	Not specified	Not specified	As issued by CRA	As issued by CRA	Principal display panel (front)	No	Symbol min 0.75"×0.75". 'Actual value may vary by 10%' disclaimer required.
Minnesota	Not specified	6 pt min	PMS 485 / Black / White (ASTM D8441)	C:0 M:100 Y:100 K:0 / K:100 / K:0	Principal display panel	No	IICPS/ASTM D8441 standard symbol. THC symbol: 0.5"×0.5" min. Warning symbol: 0.75"×0.6" min. 0.5"×0.35" is the MEDICAL symbol dimension only — never use it on adult-use artwork.
Missouri	Not specified	7 pt min	Not specified	Not specified	All product packaging, prominently on front	No	Limited to primary color + up to 2 different-colored logos/symbols. No additional colors permitted.
Montana	Times New Roman, Arial, Helvetica	Not specified	As issued by DoR	As issued by DoR	All cannabis products; 0.33"×0.33" min	No	Specific approved fonts required. Marijuana Facts Panel required on flower products.
Nevada	Not specified	8 pt min, no italics	As issued by CCB	As issued by CCB	Edible packaging and each edible serving, contrasting color	No	Universal symbol is an edibles rule only — not required on flower, vape or concentrate packs. Board approval of the packaging is required before use (NCCR 6.123).
New Jersey	Not specified	6 pt std / 10 pt high-potency and ingestible	Red/Black (per state)	PMS 485 / K:100	Each package; each individual serving where practical	Yes (FDA disclaimer when any extra claim appears)	Single color package rule. High-potency (>40% total THC) and ingestible delayed-effects warnings both 10 pt minimum. Any claim beyond the prescribed content triggers a boldface two-sentence FDA disclaimer.
New Mexico	Not specified	1/16" min	As issued by RLD	As issued by RLD	Principal display panel; 0.5"×0.5" min	Yes (bold warning text)	Bold font required for primary warning text. Symbol logo provided by RLD.
New York	Times New Roman, Calibri, Arial, Helvetica	6 pt min	As issued by OCM	As issued by OCM	Principal display panel; conspicuous via contrasting color or outline	No	Symbol cannot be altered or recolored. Square: 1.25"×1.25". Vertical: 0.5" wide. Horizontal: 0.5" tall.
Ohio	Not specified	Not specified	As issued by DCC	As issued by DCC	Container or package capable of storing cannabis; THC symbol outlined in a contrasting colour, plus the DCC seal	No	No package-level minimum size is codified. The 0.25"×0.25" floor applies to the symbol on each portion of a medical edible (OAC 3796:3-2-02(B)(3)), not to the package.
Oregon	Not specified	1/16" min	PMS 485 / Black / White	C:0 M:100 Y:100 K:0 / K:100 / K:0	Principal display panel; 0.48"×0.35" min	No	Four distinct symbols exist (Universal, Hemp, Medical Grade, ASTM). Hemp symbol floor is also 0.48"×0.35". Size is the only permitted change — enlarging is allowed, recolouring and reshaping are not. Pre-approval required, and the approval number prints on the outermost container.
Rhode Island	Times New Roman, Calibri, Arial, Helvetica	8 pt bold min	As issued by RICCC	As issued by RICCC	Front or most predominantly displayed area, 1"×1" min; vape cartridge itself may drop to 0.25"×0.25"; each individual infused serving at 25% of its width or height, never below 0.25"×0.25"	Yes (all warning text)	Approved fonts list is explicit. 8-point bold minimum on required font types. All warnings sit inside a bright yellow box. The per-serving symbol applies to every infused product, not edibles only. A single collective "Warning" heading may stand in for repeating the word on each line.
Vermont	Times New Roman, Helvetica, Arial	10 pt bold min (short statements only)	As issued by CCB	As issued by CCB	Outermost marketing-level layer; two symbols, 0.5"×0.5" min each	Yes (the two short statements)	The 10-point bold minimum and the outermost-layer rule belong to KEEP OUT OF REACH OF CHILDREN and INCLUDES MULTIPLE SERVINGS. The long mandatory health warning has no prescribed point size and may print on the interior of a durable peel-away label. Two symbols are required — IICPS triangle and NOT SAFE FOR KIDS octagon — and their sizes and colours come from CCB guidance, not from Rule 2.
Virginia	Not specified	Not specified	TBD	TBD	Principal display panel	No	Market not yet operational. No symbol artwork, dimensions or warning wording published as of September 1, 2026, the statutory deadline. Regulations expected effective January 2027; retail sales July 1, 2027.
Washington	Not specified	Not specified	PMS 485 / Black / White	C:0 M:100 Y:100 K:0 / K:100 / K:0	Principal display panel or front; 0.75"×0.75" min	Yes ('DO NOT EAT' on topicals)	Symbol cannot be altered except sizing. Two symbols required: Universal + 'Not for Kids' (edibles). 'Not for Kids' from WA Poison Center. Warning lists differ per product type, including a hyphen/en-dash split on the habit-forming statement.
Alabama	Not specified	Not specified	As issued by AMCC	As issued by AMCC	Prominent location on label	No	Medical program. For Medical Use Only designation required.
Arkansas	Times New Roman, Helvetica or Arial — closed list	8 pt (18 pt on two concentrate statements)	Not specified	Not specified	Principal display panel; 0.48"×0.35" min	Yes ('DO NOT EAT' on concentrates and extracts)	Typeface and size are prescribed, not house preference: 8 point floor in one of three named fonts, rising to 18 point minimum for the concentrate/extract patient-use and pregnancy statements. Labels must also comply with NIST Handbook 130 (2017). Activation time must be disclosed. The symbol download link written into the rule no longer resolves — request the file from ADH.
Florida	Not specified	6 pt min	MMTC logo only	White pkg only for edibles	All packaging; each edible individual serving	No	MMTC logo only — no other imagery. Edible individual wrapping: plain white, symbol only. Neon prohibited; metallic is not restricted.
Georgia	Not specified	Pharmaceutical	Pharmaceutical	Pharmaceutical	Pharmaceutical container label	No	Low-THC oil only. Max 5% THC. Standard pharmaceutical labeling applies.
Hawaii	Not specified	Not specified	Black on white ONLY	K:100 on K:0	Prominently on all packaging	No	Most restrictive design rule of any state: black text ONLY on white background. Zero exceptions for color, images, or logos.
Iowa	Not specified	Not specified	Not specified	Not specified	All medical cannabidiol packaging	No	Limited program: capsules, tinctures, oils, topicals, vaporization only.
Kentucky	Not specified	1/16" min	As issued by CHFS	As issued by CHFS	Prominent on all product packaging	No	Raw plant materials must be labeled 'not intended for consumption by smoking.'
Louisiana	Not specified	Not specified	No state symbol — LDH publishes no artwork	No state symbol	No placement rule; leave a flat panel clear for the retailer fulfillment label	No	Louisiana prescribes no symbol, no type size, no colour and no warning statement. The nine mandated label elements are applied by the retailer at fulfillment. There is no maximum container size. The 1/16 inch floor previously shown here is a Royal Supply legibility recommendation, not a Louisiana rule.
Mississippi	Not specified	Not specified	Not specified	Not specified	Edible products; all packaging references tracking ID	No	Business name and logo only — no other imagery. Seed-to-sale tracking ID required.
New Hampshire	Not specified	Not specified	ATC logo only	Plain packaging only	All cannabis product packaging	No	Plain packaging. ATC logo only imagery. Patient registry ID required on label.
North Dakota	Arial or Calibri	8 pt min	As approved by Dept.	As approved by Dept.	All cannabis product packaging	No	Arial or Calibri font required. Edibles restricted to square lozenges only.
Oklahoma	Not specified	Not specified — no type size is prescribed	Red #df1831 symbol, black text (May 2022 guidelines)	C:0 M:100 Y:85 K:6	All medical marijuana product packaging; edibles 0.5"×0.5" min in colour on the outer package and each individually packaged unit; practical floor 0.6"×0.85"	No	Label imagery is limited to the producer business name logo and an image of the product. Pre-pack effective June 1, 2025; new warning language required November 1, 2025; permanent rules effective July 11, 2026. Relabelling requires the original label to be removed, not covered. Stated potency is inaccurate if it is more than 15% off the COA.
Pennsylvania	Not specified	Not specified	No symbol required	No symbol required	No symbol; the label itself must be easily readable, conspicuously placed and firmly affixed to the immediate container and to any outer packaging	No	Prior written DoH approval of packaging and label content required. All individual terpenes above 0.0% must be listed. Four things may never appear: a resemblance to trademarked food or beverage packaging; artwork suggesting the package holds something other than medical marijuana; a seal, flag, crest, coat of arms or other insignia implying government endorsement; or anything that might make the package attractive to children.
South Dakota	Not specified	Not specified	Not specified	Not specified	All product packaging	No	Beverage measuring device required for multi-serve (10–100 mg THC) products.
Utah	Any legible font that is not script or decorative	1/16" measured on a lowercase "o"	As issued by the department (UDAF)	As issued by the department (UDAF)	No panel and no size is set by rule for the department THC warning symbol	No	No rule sizes the Utah symbol and none names a panel for it; figures circulating as Utah minimums, including the 0.26"×0.293" formerly shown here, are house or third-party numbers. The codified type rule is the 1/16 inch lowercase-o height. QR codes may ONLY link to a CoA — no other URL content permitted. Logo and brand name capped at 20% of the product face.
West Virginia	Not specified	Not specified	As approved by BPH	As approved by BPH	Prominent on all product packaging	No	Prior written BPH approval required. Graphics/cartoons strictly prohibited.

State	CR Standard	Material Thickness	Light-Resistant	Sustainability	Plastic Ban	Special Material Rules	Liquids & Beverages	Notes
Alaska	CR at point of sale per 3 AAC 306.345(a)(3) — no test standard named	Not specified	No	No	No	Resealable and child-resistant packaging required at the point of sale; opaque packaging required before the consumer exits	Multi-serving liquids must state the number and size of individual servings	Alaska names no CPSA, PPPA, 16 C.F.R. 1700 or ASTM standard. Child resistance, resealability and opacity are all duties on the retail store, so a clear, non-CR primary container plus a compliant exit package satisfies the rule and is usually cheaper.
Arizona	PPPA, CPSC, ASTM Intl.	Not specified	No	No	No	Not specified	Not specified
California	CR per CCR Div. 19	Not specified	No	No	No	Not specified	Clear glass allowed	Tamper-evident required.
Colorado	CPSA/ASTM certified	Not specified	No	No	No	Not specified	Not specified	Third-party CR certification docs required.
Connecticut	16 CFR 1700.1(b)(4)	Not specified	Yes	No	No	Multi-serving packaging must reseal and stay continuously child-resistant	Cannabis beverage: one 5 mg serving per container	Light-resistant means entirely and uniformly opaque. Packaging must be impervious and protect contents from any glue or adhesive built into it. Entirely and uniformly one colour; edibles white.
Delaware	16 CFR 1700.15	Soft-sided: 4 millimetres or greater, as codified at 5001-9.1.4	No	No	No	Multi-serving packages must be child-resistant and resealable	Beverage serving must be at least 12 ounces of liquid; edible packages capped at 10 standardized servings	Soft-sided packages need a non-resealable tamper-evident seal — heat sealing is one way to get there, not a codified requirement. Rigid packages need a tamper-evident seal plus a tight, secure lid or closure. The 4 mm soft-side thickness is written in millimetres in the rule; confirm the intended unit with OMC before tooling a pouch.
Illinois	CPSC/Poison Prevention Act	Not specified	Yes	No	No	Not specified	Not specified	Light-resistant required.
Maine	CR per 16 C.F.R. Part 1700 (2018), via 18-691 CMR ch. 30 §5	Soft-sided inhalable: 4 mil min; transdermal patches: 4 mil min, heat sealed, no easy-open tab, dimple, corner or flap; blister lidding 4 mil min	No	No	No	Every container must be resealable; multi-serving edibles child-resistant and resealable	Integral measurement component required (multi-serve liquid); hash marks do not count	Inhalables and edibles may ship in a non-child-resistant, non-tamper-evident container if the store adds child-resistant, tamper-evident exit packaging — the pack then carries the matching bold 12-point notice. Seeds are exempt from both. Serving-level wrappers and blister lidding must be white.
Maryland	16 CFR 1700.15(b)(1)	Soft: 4 mil minimum (0.004 inch)	No	No	No	Multi-serving packages must be resealable and stay child-resistant	Not specified	Soft-sided packages min 4 mil — not 4 mm. Rigid containers take either a tamper-evident seal or an adhesive band showing prior opening.
Massachusetts	16 CFR 1700	Not specified	No	No	No	Not specified	Not specified
Michigan	Rule 420.504	Not specified	No	No	No	Not specified	Not specified	Tamper-evident closure required.
Minnesota	CR per Minn. Stat. 342.62	Not specified	Yes	No	No	Multi-serving packages must reseal	LPHE beverage: 10 mg/container; multi-serving 750 ml+ at 5 mg/serving, 17 servings max	No PFAS in the packaging or any coating. Edible packaging must use FDA-approved food-contact materials. Only exemption from child resistance is an LPHE intended to be drunk.
Missouri	CR certified	Not specified	No	No	No	Not specified	Not specified	State review and approval of packaging required before sale.
Montana	Third-party CR testing	Not specified	No	No	No	Not specified	Not specified	Documentation from federally qualified third-party CR testing firm required. Exit package also required.
Nevada	16 CFR 1700	Not specified	No	No	No	Max 1/8 oz per pkg	Not specified	Single-package limits: max 1 oz usable cannabis. Tincture/topical: max 800 mg THC/package.
New Jersey	16 CFR Part 1700	Not specified	Yes	Good-faith biodegradable effort required	No	Not specified	Not specified	Single solid color required. Light-resistant required. Biodegradable packaging is a regulatory expectation.
New Mexico	CR per 16.8.3.12.A(3); 16 C.F.R. 1700.15/1700.20 certificate for edible and topical containers	Not specified	No	Compostable/recyclable/recycled materials required	No	Multi-serving or multi-use containers must reseal and stay continually child-resistant	Liquid finished products are single-serving only, unless one cap mechanism delivers both child resistance and accurate pouring measurement	Flower-only finished products are expressly exempt from the child-resistant container requirement and need only a resealable container. Opacity applies to the retailer exit package, not the product container.
New York	16 CFR 1700.15 & 1700.20 (documentation required)	Not specified	No	25% post-consumer recycled plastic required	No	Not specified	Not specified
Ohio	CR per OAC 3796:3-2-02	Not specified	Yes	No	No	Not specified	Not specified	Light-resistant required.
Oregon	Third-party CR certified	Not specified	No	No	No	Not specified	Not specified	CR certification by qualified third-party firm required. No nicotine, caffeine, or potency-enhancing additives permitted.
Rhode Island	CR per state rules	Not specified	No	No	No	Not specified	Not specified	Tamper-evident with visible evidence of disturbance required.
Vermont	CR per CCB rules	Not specified	No	No	Yes — retail plastic banned for adult-use	Not specified	Not specified	Cannabis flower, trim, and pre-rolls exempt from CR requirement. CCB maintains approved plastic-free packaging list.
Virginia	16 CFR 1700.1(b)(4)	Not specified	Yes	No	No	Not specified	Not specified	Market not yet operational. FDA 21 CFR Part 111 cGMP standards required.
Washington	16 CFR Part 1700	Concentrates: 2 mil min polyethylene	No	No	No	2 mil+ polyethylene, heat-sealed, no easy-open features	Not specified	Two-form CR requirement: single-use for singles, resealable for multi-serve.
Alabama	CR + tamper-evident	Not specified	No	No	No	Not specified	Not specified
Arkansas	Child-proof per 20 CAR 810-1301(a)(2)(B), tested to 16 C.F.R. 1700.20 as existing January 1, 2017	Not specified	No	No	No	Not specified	Not specified	Sealed, traceable and food compliant. No opacity requirement exists in either the Commission packaging rule or the Department labeling rules — clear stock is compliant. No certificate or filing is required; the certificate Royal Supply asks converters for is a sourcing standard.
Florida	CR + resealable	Not specified	No	No	No	Not specified	Not specified	Plain, single solid color. White for edible individual wrappers. No neon or metallic finishes.
Georgia	Pharmaceutical CR	Not specified	No	No	No	Not specified	Not specified	Standard pharmaceutical container. Low-THC oil only.
Hawaii	16 C.F.R. Part 1700	Not specified	No	No	No	Not specified	Not specified
Iowa	CR + tamper-evident	Not specified	No	No	No	Not specified	Not specified
Kentucky	2-step CR process required	Not specified	Yes	No	No	Not specified	Not specified	Opaque to protect from light degradation.
Louisiana	None — Louisiana requires no child-resistant packaging	Not specified	Light-impermeable (not the USP term light-resistant)	No	No	Not required	Not specified	The only physical specification in force is that the product be packaged in tightly-sealed and light-impermeable packaging when provided to the patient, and it is written as a retailer duty at LAC 51:XXIX.2507.E. There is no maximum container size; the 71 g per 14 days figure is a dispensing cap on the retailer. Subpart 1, Marijuana Manufacturers, imposes no packaging or labeling requirement at all.
Mississippi	16 CFR 1700.15	Not specified	No	No	No	Not specified	Not specified	Resealable CR required for multi-serving edibles.
New Hampshire	CR + tamper-proof	Not specified	No	No	No	Not specified	Not specified	Patient may request CR exemption in writing.
North Dakota	Dept.-approved CR	Not specified	No	No	No	Not specified	Not specified	Edibles restricted to square lozenges only.
Oklahoma	CR per OAC 442:10-7-1(d)(3)	Not specified	No	No	No	Not required — Oklahoma sets no resealability rule; retail units ship sealed	Not specified	Container may be clear so the patient can see the product; the dispensary supplies an opaque exit package. Flower-based retail units run 0.5 g to 3 oz. Pre-pack rules effective June 1, 2025; permanent rules effective July 11, 2026. Dispensaries may not reopen a pre-packaged unit except to make non-infused pre-rolls or display samples up to 3.5 g.
Pennsylvania	CR + tamper-proof or tamper-evident	Not specified	Opaque required — dry leaf expressly exempt	No	No	Resealable required on every package	Not specified	The rule says opaque, never light-resistant, and carves dry leaf out of the opacity requirement by name. Packaging must also minimise exposure to oxygen and be clearly distinguishable from any other package of similar appearance. Prior DoH written approval of packaging and label content is required before production.
South Dakota	CR per SD Admin Rules	Soft: 4 mil min; Rigid: tight-fitting lid	No	No	No	Not specified	Measuring device required for multi-serve beverages
Utah	CR per CPSC standards; tamper-evident and tamper-resistant	Not specified	No — Utah has no opacity rule	No	No	Not required	Not specified	Cannot appeal to children or mimic candy or a candy container. Shapes on packaging or labeling may not resemble the product or real-world items. Label, logo, brand name and packaging need UDAF pre-approval before distribution.
West Virginia	CR + light-resistant	Not specified	Yes	No	No	Not specified	Not specified	Prior BPH written approval required.

Know Before You Print

Packaging Rules & Pre-Approval

What you can’t put on a package — and the 13 states where regulators must sign off on your packaging before it ships.

Colors

1Neon / Fluorescent Colors. FL (medical), NJ — explicitly prohibited. Neon and metallic colors on medical packaging prohibited in Florida.

2Metallic Colors / Metallic Finishes. FL — metallic colors on medical packaging explicitly prohibited.

3Bright Colors Appealing to Children. DE, WA, OH, CO, MT — packaging must not use bright colors or designs likely to appeal to children.

4Single-Color Exception. NJ — packaging must be a single solid color; the state universal symbol and one logo/brand mark are the only permitted color exceptions (max 1"×1").

5Limited Color Palette. MO — primary color plus up to two logos/symbols of a different color only. Severely limits multi-color branding.

Shapes & Physical Forms

1Human Shape / Form. CO, MI, MO, NJ, ND, DE — product cannot be shaped or packaged to resemble a human figure (realistic, artistic, caricature, or cartoon).

2Animal Shape / Form. CO, MI, MO, NJ, ND — product or package cannot resemble an animal in any form.

3Fruit / Vegetable Shape. CO, MI, MO, NJ, MN — cannot be shaped like or depicted as fruits or vegetables (exception in MN: accurate ingredient depiction only).

4Insect Shape. AZ — packaging cannot be shaped or designed to resemble insects.

5Toy Shape. AZ — packaging is prohibited from resembling toys or toy packaging.

6Square Lozenges Only (ND). ND Medical — edible products restricted to hard or soft lozenges in square shape only.

Characters & Imagery

1Cartoon Characters. All states — universally prohibited. Cannot use, depict, or suggest cartoon characters on any cannabis packaging.

2Animated Characters. All states — same as cartoon characters.

3Pop Culture Icons / Fictional Characters. OH — explicitly prohibits reference to or resemblance of pop culture icons or fictional characters that target children.

4Images Appealing to Minors. All states — any image that specifically appeals to or targets individuals under 21 is prohibited.

5Product Images (FL Medical). FL — no product images or graphics allowed whatsoever except the MMTC logo (department-approved only).

6Any Images Except Logo (NH). NH — packaging cannot depict the product, cartoons, or images other than the Alternative Treatment Center (ATC) logo.

7Imagery Other Than Business Name/Logo (MS). MS — packaging cannot depict images other than the business name and registered logo.

Text & Words

1'Candy' or 'Candies'. CO — the words 'candy' or 'candies' cannot appear anywhere on packaging unless they are part of the licensed establishment's legal name.

2Cannabis Slang Terminology (ND). ND — logos and branding are prohibited from including marijuana slang terminology.

3False/Misleading Therapeutic Claims. All states — packaging cannot make claims suggesting unapproved health or therapeutic benefits.

4False/Misleading Statements. VT, KY, various — packaging cannot contain any false or misleading statements whatsoever.

5References to FDA Approval. MA, VT, NH — must not suggest FDA approval; instead required to state the product has NOT been approved by the FDA.

6Medical Symbols Resembling Official Associations (ND). ND — cannot include logos or branding that include medical symbols resembling official medical associations.

7Government Insignia Suggesting Endorsement (KY). KY — packaging cannot include government insignia in a manner suggesting official government endorsement.

Copycat / Brand Imitation

1Existing Food / Snack Brand Imitation. NY, VA, KY, DE — packaging cannot imitate or be designed to look like existing branded food, snack, baked goods, or beverage products.

2Candy Brand Imitation. MN, NM, CO, WA — cannot use brand names or designs imitating or mimicking candies, cereals, or foods marketed to children.

3Candy/Food Product Look-Alike. CA, CO, ME, WA, NH — products and packaging must be distinct from commercially sold candy, food, and children's consumer products.

4Federal Trademark Infringement. ME, NY — packaging may not violate federal trademark law or use copycat trademarks of other commercial products.

Environmental & Material Restrictions

1Retail Plastic Packaging (VT). VT — plastic packaging for adult-use products is prohibited at retail. Must use CCB-approved plastic-free packaging options. Medical products have an exception.

2Non-Biodegradable Packaging (NJ preference). NJ — licensees must make a good-faith effort to utilize biodegradable packaging. While not an absolute ban, it is a regulatory expectation.

3Non-Recycled Plastic (NY). NY — plastic packaging must contain a minimum of 25% post-consumer recycled content.

4Non-Compostable/Non-Recyclable Materials (NM). NM — containers must be compostable, recyclable, or made from recycled materials.

Missouri

DHSS, Division of Cannabis Regulation

Requirement. State review and approval of ALL packaging and labeling required before any product can be sold.

What to submit. Packaging samples, label artwork, and product specifications submitted to DHSS for review.

⏱ Varies; allow 30–60 days

Agency Portal ➞

Nevada

Cannabis Compliance Board (CCB)

Requirement. Pre-approval from the CCB is required before any product launch. Packaging must be reviewed and approved.

What to submit. Label application with artwork, product specs, and testing documentation.

⏱ Allow 4–8 weeks

Agency Portal ➞

Oregon

Oregon Liquor and Cannabis Commission (OLCC)

Requirement. Labels and packaging must receive OLCC pre-approval before any product is sold at retail.

What to submit. Label/packaging artwork submitted through OLCC Licensing Portal.

⏱ Allow 4–6 weeks; expedited review available

Agency Portal ➞

Pennsylvania

Department of Health, Bureau of Medical Marijuana

Requirement. Prior written approval from the Department of Health is required for ALL packaging and label content before production.

What to submit. All label content, artwork, and packaging specs submitted to PA DoH for written approval.

⏱ Allow 30–60 days

Agency Portal ➞

West Virginia

DHHR Bureau of Public Health, Office of Medical Cannabis

Requirement. Prior written approval from DHHR Bureau of Public Health is required for all packaging and label content before use.

What to submit. All label content and packaging designs submitted to DHHR BPH.

⏱ Allow 30–60 days

Agency Portal ➞

Washington

Washington State Liquor and Cannabis Board (LCB)

Requirement. Cannabis processor label and packaging must be approved by LCB before sale. Recipes for cannabis-infused products must first be approved by WA Dept. of Agriculture.

What to submit. Label/packaging through LCB's Cannabis Licensing System. Recipes to WA Dept. of Agriculture first.

⏱ Allow 4–6 weeks for label approval

Agency Portal ➞

Maryland

Maryland Cannabis Administration (MCA)

Requirement. All labels must link to a Certificate of Analysis (CoA) via QR code or URL (effective January 1, 2024). Packaging design must bear the MCA-approved symbol.

What to submit. CoA generated per batch; symbol obtained from MCA. No full pre-approval process but MCA symbol use is required.

⏱ Ongoing per batch

Agency Portal ➞

Oklahoma

Oklahoma Medical Marijuana Authority (OMMA)

Requirement. All flower-based products must be pre-packaged and meet OMMA labeling standards before dispensary transfer (effective June 1, 2025).

What to submit. Products must meet OMMA packaging standards; compliance verification through seed-to-sale system.

⏱ Effective June 1, 2025

Agency Portal ➞

Montana

Montana Department of Revenue, Cannabis Control Division

Requirement. Exit package approval is required before any product leaves a licensed facility for retail transfer. Additionally, child-resistant certification documentation from a federally qualified third-party testing firm must be on file.

What to submit. Exit package designs submitted to DoR Cannabis Control Division for approval. CR certification from qualified third-party firm must be maintained and available upon request.

⏱ Allow 2–4 weeks for exit package approval

Agency Portal ➞

North Dakota

ND Dept. of Health and Human Services, Division of Medical Marijuana

Requirement. All packaging must be approved by the Department before any product is dispensed. Packaging designs must meet the Department's plain, opaque, tamper-evident requirements.

What to submit. Packaging designs and label artwork submitted to NDHHS Division of Medical Marijuana for approval.

⏱ Allow 2–4 weeks

Agency Portal ➞

Florida

Office of Medical Marijuana Use (OMMU), FL Dept. of Health

Requirement. The MMTC (Marijuana Treatment Center) logo used on packaging must be approved by the Department. No other images or graphics are permitted. All edible individual wrapping with the universal symbol must conform to OMMU requirements.

What to submit. MMTC logo design submitted to OMMU for department approval before use.

⏱ Varies; contact OMMU directly

Agency Portal ➞

Maine

Office of Cannabis Policy, Dept. of Administrative and Financial Services

Requirement. Voluntary pre-approval is available: licensees may submit labeling for review before printing. While not mandatory, this option reduces the risk of non-compliant labels reaching retail.

What to submit. Label artwork submitted to OCP for voluntary pre-approval review.

⏱ Voluntary; allow 2–3 weeks if pursued

Agency Portal ➞

Kentucky

Cabinet for Health and Family Services (CHFS), Office of Medical Cannabis

Requirement. Voluntary compliance review is available: cannabis businesses may submit packaging designs for pre-production review. While not mandatory, CHFS recommends this step to avoid non-compliant products reaching dispensaries.

What to submit. Packaging and label designs submitted to CHFS Office of Medical Cannabis for voluntary compliance review.

⏱ Voluntary; allow 2–4 weeks if pursued

Agency Portal ➞

Straight From The Source

Agencies & Regulatory Updates

Direct contacts for every state cannabis regulator, plus a running log of packaging and labeling rule changes tracked by our compliance team.

Alaska

Adult-Use & Medical

Alcohol & Marijuana Control Office (AMCO)

🔖 3 AAC 306
📞 907-269-0350
✉ marijuana.licensing@alaska.gov
Official site ➞

Arizona

Adult-Use & Medical

AZ Dept. of Health Services (ADHS), Bureau of Marijuana Licensing

🔖 9 A.A.C. 18
📞 602-542-1025
✉ m2programsupport@azdhs.gov
Official site ➞

California

Adult-Use & Medical

Department of Cannabis Control (DCC)

🔖 CCR Title 4, Division 19
📞 844-612-2322
✉ See cannabis.ca.gov/contact
Official site ➞

Colorado

Adult-Use & Medical

Dept. of Revenue, Marijuana Enforcement Division

🔖 1 CCR 212-3
📞 303-866-3330
✉ heather.draper@state.co.us
Official site ➞

Connecticut

Adult-Use & Medical

Department of Consumer Protection (DCP)

🔖 CT Gen. Statutes Ch. 420h; Public Act 26-8 (2026)
📞 860-713-6065
✉ dcp.cannabis@ct.gov
Official site ➞

Delaware

Adult-Use & Medical

Office of the Marijuana Commissioner (OMC)

🔖 DE Code Title 4, Ch. 13
📞 302-244-3662
✉ omc@delaware.gov
Official site ➞

Illinois

Adult-Use & Medical

Cannabis Regulation Oversight Office (CROO) / IDFPR

🔖 410 ILCS 705/55-21
📞 Not published
✉ FPR.CROO@Illinois.gov
Official site ➞

Maine

Adult-Use & Medical

Office of Cannabis Policy, Dept. of Administrative & Financial Services

🔖 ME Rev. Stat. Title 28-B §701
📞 207-287-3282
✉ See maine.gov/dafs/ocp/contact
Official site ➞

Maryland

Adult-Use & Medical

Maryland Cannabis Administration (MCA) / ATCC

🔖 COMAR 14.17
📞 410-487-8100
✉ mlapp.support@cannabis.maryland.gov
Official site ➞

Massachusetts

Adult-Use & Medical

Cannabis Control Commission (CCC)

🔖 935 CMR 500.105
📞 774-415-0200
✉ Commission@CCCMass.com
Official site ➞

Michigan

Adult-Use & Medical

Cannabis Regulatory Agency (CRA)

🔖 MI Admin Code Rule 420.504
📞 517-284-8599
✉ CRA-Info@michigan.gov
Official site ➞

Minnesota

Adult-Use & Medical

Office of Cannabis Management (OCM)

🔖 MN Stat. Ch. 342
📞 651-201-5598
✉ medical.cannabis@state.mn.us
Official site ➞

Missouri

Adult-Use & Medical

DHSS, Division of Cannabis Regulation

🔖 19 CSR 100
📞 866-219-0165
✉ Cannabisinfo@health.mo.gov
Official site ➞

Montana

Adult-Use & Medical

Montana Dept. of Revenue, Cannabis Control Division

🔖 ARM 42.39
📞 406-444-0596
✉ DORCCD@mt.gov
Official site ➞

Nevada

Adult-Use & Medical

Nevada Cannabis Compliance Board (CCB)

🔖 NRS Ch. 678D / NAC Ch. 453D
📞 775-687-6299
✉ CCBLicensing@ccb.nv.gov
Official site ➞

New Jersey

Adult-Use & Medical

NJ Cannabis Regulatory Commission (CRC)

🔖 NJAC 17:30
📞 609-376-7300
✉ crc.muni@crc.nj.gov
Official site ➞

New Mexico

Adult-Use & Medical

NM Regulation and Licensing Dept. (RLD), Cannabis Control Division

🔖 NMAC 16.8.3
📞 Not published
✉ ccd.licensing@rld.nm.gov
Official site ➞

New York

Adult-Use & Medical

New York Office of Cannabis Management (OCM)

🔖 Part 128 Adult-Use Regulations
📞 888-626-5151
✉ info@cannabis.ny.gov
Official site ➞

Ohio

Adult-Use & Medical

Ohio Department of Cannabis Control (DCC)

🔖 OAC 3796:3-2-02
📞 833-464-6627
✉ DCCLicensing@com.ohio.gov
Official site ➞

Oregon

Adult-Use & Medical

Oregon Liquor and Cannabis Commission (OLCC)

🔖 OAR 845-025-7000
📞 503-872-5207
✉ marijuana.packaging@olcc.oregon.gov
Official site ➞

Rhode Island

Adult-Use & Medical

Rhode Island Cannabis Control Commission (RICCC)

🔖 RI Gen. Laws Ch. 21-28.11
📞 401-889-5607
✉ CCCInquiry@ccc.ri.gov
Official site ➞

Vermont

Adult-Use & Medical

Vermont Cannabis Control Board (CCB)

🔖 VT Title 6 V.S.A. Ch. 33
📞 802-636-7548
✉ CCB.Info@vermont.gov
Official site ➞

Virginia

Adult-Use & Medical

Virginia Cannabis Control Authority (CCA)

🔖 VA Code Title 4.1, Ch. 16
📞 Not published
✉ See cca.virginia.gov/contact
Official site ➞

Washington

Adult-Use & Medical

Washington State Liquor and Cannabis Board (LCB)

🔖 WAC 314-55-105/106
📞 360-664-1693
✉ marijuana.licensing@lcb.wa.gov
Official site ➞

Alabama

Medical Only

Alabama Medical Cannabis Commission (AMCC)

🔖 AL Admin. Code 538-X-6
📞 Not published
✉ patientregistry@amcc.alabama.gov
Official site ➞

Arkansas

Medical Only

AR Dept. of Finance & Administration, Medical Marijuana Commission

🔖 AR Admin. Code
📞 501-682-4982
✉ mmcstaff@dfa.arkansas.gov
Official site ➞

Florida

Medical Only

Office of Medical Marijuana Use (OMMU), FL Dept. of Health

🔖 FL Stat. §381.986
📞 800-808-9580
✉ medicalmarijuanause@flhealth.gov
Official site ➞

Georgia

Medical Only

Georgia Access to Medical Cannabis Commission (GMCC)

🔖 GA Medical Cannabis Program / SB 220 (2026)
📞 Not published
✉ See gmcc.ga.gov/contact
Official site ➞

Hawaii

Medical Only

Office of Medical Cannabis Control & Regulation (OMCCR), HI DoH

🔖 HRS 329D / HAR Ch. 11-850
📞 Not published
✉ See health.hawaii.gov/medicalcannabis
Official site ➞

Iowa

Medical Only

Iowa Dept. of Health and Human Services

🔖 Iowa Code Ch. 124E / 641 IAC 154
📞 Not published
✉ See hhs.iowa.gov/contact
Official site ➞

Kentucky

Medical Only

Cabinet for Health & Family Services (CHFS), Office of Medical Cannabis

🔖 915 KAR 1:100
📞 Not published
✉ See kymedcan.ky.gov/contact
Official site ➞

Louisiana

Medical Only

Louisiana Dept. of Health (LDH), Cannabis Program

🔖 LA Admin. Code
📞 Not published
✉ See ldh.la.gov/contact
Official site ➞

Mississippi

Medical Only

MS State Dept. of Health, Medical Cannabis Program (MMCP)

🔖 MMCP Packaging Guide v1.0
📞 Not published
✉ See mmcp.ms.gov/contact
Official site ➞

New Hampshire

Medical Only

NH Dept. of Health and Human Services (DHHS)

🔖 He-C 402
📞 Not published
✉ See dhhs.nh.gov/contact
Official site ➞

North Dakota

Medical Only

ND Dept. of Health and Human Services (NDHHS)

🔖 ND Admin. Code 33-44-01
📞 Not published
✉ See hhs.nd.gov/mm
Official site ➞

Oklahoma

Medical Only

Oklahoma Medical Marijuana Authority (OMMA)

🔖 OAC 310:681
📞 405-522-6662
✉ OMMACommunications@omma.ok.gov
Official site ➞

Pennsylvania

Medical Only

PA Dept. of Health, Bureau of Medical Marijuana

🔖 28 Pa. Code §1151a.34
📞 888-733-5595
✉ See pa.gov/agencies/health/programs/medical-marijuana
Official site ➞

South Dakota

Medical Only

SD Dept. of Health, Medical Cannabis Program

🔖 SD Admin. Rules 44:90
📞 Not published
✉ See doh.sd.gov/contact
Official site ➞

Utah

Medical Only

Utah Dept. of Agriculture and Food (UDAF) — transition from DHHS in progress under HB 389/SB 121 (complete by Jan. 1, 2027)

🔖 Utah Admin Code R66-2-13
📞 801-538-6504
✉ pharmacy@health.utah.gov
Official site ➞

West Virginia

Medical Only

WV Office of Medical Cannabis, Bureau for Public Health

🔖 W. Va. Code R. 64-110-16
📞 304-356-5090
✉ medcanwv@wv.gov
Official site ➞

Sorted newest first

January 1, 2028 (operative date, if signed)CaliforniaAB 2249 passed both houses (Senate 37-0 on August 19, 2026; Assembly concurrence 69-1 on August 20, 2026) and was enrolled and presented to the Governor on August 27, 2026. It would add Bus. & Prof. Code 26141, defining 'attractive to children' as designed or likely to appeal to individuals under 21 and barring packaging that imitates a noncannabis product primarily marketed to children, along with cartoon or overly stylized depictions of fruit on edible and vape-cartridge labeling. New section 26142 directs the department to publish voluntary compliance assessment resources, expressly outside the Administrative Procedure Act and advisory only. Not signed as of August 31, 2026; section 26141 becomes operative January 1, 2028. The enrolled text contains no standardized-rubric mandate and no July 1, 2027 deadline — the earlier version's rubric requirement was removed by the August 13, 2026 Senate amendment. source ➞ Upcoming

Retail sales July 1, 2027VirginiaChecked on September 1, 2026, the statutory deadline for the Cannabis Control Authority to promulgate adult-use regulations and open applications. Nothing has been promulgated: no draft or final packaging or labeling regulation, no universal symbol artwork and no Board-adopted warning wording. The CCA's Retail Marijuana Market page carries the same schedule as in August — draft regulations September 2026, finalized December 2026, effective January 2027, conversion applications February 1, 2027, preliminary licenses May 1, 2027, retail sales July 1, 2027. Adult-use proofs stay on hold; January 2027 is the earliest the specifications can exist. source ➞ Upcoming

January 1, 2027VirginiaAdult-use retail framework passed by General Assembly March 2026. CCA must promulgate final packaging/labeling regulations by September 1, 2026. Retail sales confirmed for January 1, 2027. source ➞ Upcoming

2027 (if enacted)LouisianaHB 373 filed February 2026: Adult-Use Cannabis Pilot Program. Would authorize recreational sales 2027-2030 through existing medical licensees. Pending House Health and Welfare Committee. source ➞ Upcoming

October 1, 2026ConnecticutPublic Act 26-8 s 79, signed May 22, 2026, takes effect October 1, 2026. The high-potency warning at C.G.S. s 21a-421j(5)(L) expands from cannabis concentrate to cannabis flower and other cannabis plant material above 30 per cent total THC. The 35 per cent cap on flower and other plant material is repealed, and the 70 per cent cap ceases to apply to concentrates, flower, other plant material and prefilled cartridges. The department also loses its power to adjust those percentages by regulation. Mold remediation is handled by dispensary signage rather than by a label statement. source ➞ Upcoming

August 22, 2026MontanaThe conforming rule amendment behind the July 1, 2026 statutory changes now exists and is in force. MAR Notice No. 2026-93.2, the Department of Revenue's Notice of Adoption, amends ARM 42.39.122, 42.39.314 and 42.39.319 effective August 22, 2026 to implement HB 792 (2025). 42.39.314, General Labeling Requirements, was adopted as proposed; 42.39.122 and 42.39.319 were adopted with one change, to the URL from which licensees download the department's QR code and consumer education poster. Two packaging requirements confirmed from the adopted text were missing from this page and have been added: a drinkable product with more than one serving per package must include a device or mechanism for measuring a single serving, and exit packaging may carry no information or design element beyond what 16-12-208(6)(b)(ii), MCA allows. The four statutory warning strings were also compared this cycle against the department's own printed exit-bag label artwork and match word for word. source ➞ In Effect

August 1, 2026MinnesotaSF 4401 labeling provisions in effect: cultivator information no longer required on cannabinoid product labels; lower-potency hemp edibles may use a scannable QR code for source information. Macrobusiness license category still effective January 1, 2027. source ➞ In Effect

July 11, 2026OklahomaOMMA permanent rules effective July 11, 2026 (43 Ok Reg 1019), superseding the July 2025 emergency rules and implementing HB 2807, SB 518, SB 774, SB 1039, SB 1066: verbatim impaired-driving and pregnancy warnings, pre-pack mandate (sealed retail units; no in-store bulk-flower packaging), packaged-on date added to the label element list, label imagery limited to the producer business name logo and an image of the product. The adopted text prescribes no minimum warning font size. source ➞ In Effect

July 1, 2026Montana[IN EFFECT as of July 1, 2026] DoR Cannabis May 2026 Newsletter (May 5, 2026) confirms July 1, 2026 effective date for: (1) revised exit-packaging warnings (four verbatim statutory warnings under 16-12-215 MCA, in BLACK INK on WHITE BACKGROUND, placed next to the universal symbol) + addiction-resource QR code on all exit packaging; (2) new consumer education poster at each POS (with updated warnings, universal symbol, and addiction-resource URL/phone/QR); (3) ingestible THC per-serving cap reduced from 10 mg to 5 mg (products labeled >5 mg per serving may not be sold after that date). Licensees are NOT required to resubmit exit packaging — compliance verified during inspection. DoR will no longer review/approve advertising scripts; new Cannabis Business Marketing & Advertising Guide is the compliance reference. Updated generic label templates available at no cost. source ➞ In Effect

May 12, 2026GeorgiaGovernor Brian Kemp SIGNED SB 220 ('Putting Georgia's Patients First Act') into law on May 12, 2026. The law (1) replaces the 5% THC potency cap with a 12,000 mg THC patient possession limit, (2) permits vaporization for patients 21+, (3) adds lupus and intractable pain to qualifying conditions (HIV and Inflammatory Bowel Disease previously added during the expansion), (4) replaces statutory 'low THC oil' terminology with 'medical cannabis,' and (5) extends patient registry card validity to five years. Georgia becomes the 41st medical cannabis state under the modernized framework. source ➞ In Effect

May 4, 2026AlabamaAMCC confirmed first medical-cannabis dispensary sales begin May 4, 2026 at Callie’s Apothecary (Montgomery), with additional dispensaries (e.g., Specialty Medical Products of Alabama, Wagon Trail Med-Serv) expected to open in subsequent weeks. Permitted forms remain non-smokable: tablets, capsules, tinctures, patches, oils, gels, and gummies (peach-flavored only). source ➞ In Effect

April 29, 2026MaineLD 1847 (132nd Legislature) DIED ON ADJOURNMENT April 29, 2026. It would have instituted mandatory testing and tracking for medical cannabis, defined high-potency product and required blister packaging for gummies. Reported out April 10, 2026 with a divided committee report and never taken up. No packaging or labeling requirement follows from it. source ➞ Did Not Take Effect

April 23, 2026FederalDOJ/DEA final order (April 23, 2026) places FDA-approved marijuana products and qualifying state-licensed medical marijuana into Schedule III of the CSA. DEA registrants may rely on state-law packaging, labeling, disposal, and physical-security requirements in lieu of otherwise-applicable federal requirements, subject to inclusion of the 21 U.S.C. §825(c) statutory warning label. source ➞ In Effect

April 19, 2026MassachusettsH.5350 'An Act Modernizing the Commonwealth’s Cannabis Laws' signed by Governor Healey on April 19, 2026. Adult possession/purchase doubled to 2 oz flower (or 10 g concentrate / 1,000 mg THC edibles); per-operator retail license cap raised from 3 to 6; CCC restructured from 5 commissioners to 3 (gubernatorial appointments). CCC issued Bulletin No. 1 (April 17, 2026) and Administrative Order on equivalency/conversion standards (April 19, 2026); equivalency rulemaking in progress. source ➞ In Effect

April 17, 2026MinnesotaOCM Guidance Memo GM-2025-05 updated April 17, 2026 — clarifies authorized propagation-source rules (post-Dec 1, 2025): cultivators must use Metrc-tracked propagative materials from an OCM-authorized source; farmer-saved seeds approved; newly licensed cultivators receive a 30-day external transfer window to add genetics on hand or previously acquired from authorized sources. source ➞ In Effect

April 8, 2026Rhode IslandFederal court injunction (April 8, 2026) halted issuance of new retail cannabis licenses statewide pending litigation over RI’s residency requirement; ~97 pending applications and up to 20 retail licenses are now on hold. Existing licensees and packaging/labeling rules unaffected; only new license rollout is paused. source ➞ In Effect

April 1, 2026MinnesotaChapter 342 full compliance deadline April 1, 2026: all cannabis and lower-potency hemp products must meet updated packaging/labeling standards. OCM Packaging and Labeling Guide published. source ➞ In Effect

April 2026KentuckyMulti-dispensary expansion in April 2026: Speakeasy Dispensary (Princeton) opened April 10; Mallard Club LLC opened April 13; NatureMed Cannabis Dispensary (11th statewide) opened in late April. Product range expanding from flower to vape cartridges, concentrates, and gelatin-free gummies (Alchemy strain-specific distillate vape cartridges launched week of April 20). source ➞ In Effect

March 20, 2026OhioSB 56 signed December 19, 2025 (effective March 20, 2026): original-packaging mandate for possession; intoxicating hemp banned outside licensed dispensaries. source ➞ In Effect

March 20, 2026OhioSB 56 now in effect (March 20, 2026): non-medical THC limits raised to 500 mg/serving and 1,500 mg/package for processed forms; 15,000 mg daily purchase limit; original-packaging possession mandate. source ➞ In Effect

March 4, 2026MissouriDCR variance issued March 4, 2026: humidity control (moisture) packets now permitted in final product packaging if using FDA-approved food contact substances and noted in item approval application. source ➞ In Effect

February 2026Missouri'Verified Dispensary: We're on the List' initiative launched February 2026 with state-issued decals and interactive dispensary map. source ➞ In Effect

February 2026VermontCCB February 2026 board meeting: no new packaging-rule waiver applications will be accepted until 2027; product-labeling definitions clarified — 'Live' now describes cannabis cured by flash-freezing and freeze-drying, and currently registered products that fail to meet the clarified definitions must update labeling at next product registration renewal. Plastic-packaging prohibition (Rule 2.2.9(b)) remains in effect. source ➞ In Effect

January 20, 2026WashingtonHB1636, HB1698, 2SSB5786 implementation rules effective January 20, 2026. Allows loose packaging for solid edibles without individual wrapping; digital batch-level traceability. source ➞ In Effect

January 12, 2026New JerseyP.L.2025, c.215 signed January 12, 2026: regulates intoxicating hemp-derived products. Governor Sherrill signed amendments March 31, 2026 revising hemp beverage restrictions (resealable packaging required for >10 mg THC containers, max 750 mL volume). source ➞ In Effect

January 5, 2026ColoradoHB25-1209 streamlining rules adopted; revised MED rules effective January 5, 2026. Decontaminated product labeling required since July 1, 2025. source ➞ In Effect

Ten days after publication in the June 2026 Delaware RegisterDelawareEdible and tincture package caps have gone up, and this hub was publishing the superseded figures. A Final Order signed May 8, 2026 and published in the June 2026 Delaware Register adopted the April 1, 2026 proposal at 29 DE Reg. 846 without change; by its own terms it took effect ten days after publication. An edible package may now hold 100 mg of THC rather than 50 mg and 10 standardized servings rather than 5 (5001-9.3.1.2 and 8.3.1.1), and a tincture package 500 mg rather than 300 mg (5001-8.3.1.3). One conflict came with it: 8.3.1.2 now caps a multi-serving beverage package at 100 mg while 9.3.2.2, untouched by the order, still caps a marijuana beverage package at 60 mg. This hub publishes 60 mg, which satisfies both, and says to ask the Commissioner before building higher. source ➞ In Effect

June 12, 2026 (in effect)IllinoisThe dispensary name is no longer a required label element and has been removed. P.A. 104-463, effective June 12, 2026, struck 410 ILCS 705/15-70(b), the subsection that required it; the Illinois General Assembly now prints that subsection as "(Blank)." IDFPR says the same thing in its own SB 3222 fact sheet of June 23, 2026: "The specific dispensary name is no longer required to be included on cannabis products prior to sale." Neither 410 ILCS 705/55-21 nor 8 Ill. Adm. Code 1300.930(b) requires it — both name the cultivation center or craft grower instead. Anyone reserving panel space for a dispensary-applied name on adult-use artwork can reclaim it. source ➞ In Effect

June 2026 edition (in effect)MississippiResealability scope corrected. This hub said resealability attached only to multi-serving edibles and told buyers that single-serving edibles and all non-edible products were exempt. Rule 6.1.9 applies to all usable retail-ready cannabis and cannabis products, and 6.1.9(6) requires a resealable container meeting 16 CFR 1700.15 whenever the product contains more than one serving. A multi-serving flower jar, tincture or vape pack is in scope. source ➞ In Effect

June 2026 edition (in effect)MississippiThe topical route-of-administration statement is codified, not guidance. Rule 6.1.7 requires all labeling on topical products to state "For Topical Application - Do Not Eat or Smoke", quoted in the rule in title case with an en dash and no terminal period. This hub carried it as agency-guide wording with no rule citation and printed a mixed-case variant ending in a full stop. The two other prescribed strings were also re-set to their codified form: 6.1.4(3) quotes "Keep out of reach of children" in sentence case and 6.1.4(9) quotes "extremely potent" in lower case, where this hub published both in full capitals. Capitalization is not prescribed and MSDH's own guide renders all three differently, so an existing all-capitals label is not thereby non-compliant. source ➞ In Effect

June 2026 edition (in effect)MississippiEdible dose disclosure narrowed by the June 2026 edition, and an invented shape rule removed. Rule 6.1.4(10) no longer requires a clear determination of how much total THC is in a single serving and in the entire package; what remains is the number of servings, the single serving size and the plus-or-minus-10% variance statement. The package-level total THC and CBD figures are still required, but by 6.1.4(11)(h). Separately, this hub published "molded edibles must be geometric shapes"; that requirement appears nowhere in Subpart 6 or in MSDH's Packaging and Labeling Guide and has been withdrawn. Homogenization and the 30%/60% total THC ceilings were re-cited to their actual sources, R. 5.1.4 and R. 5.4.6. source ➞ In Effect

July 1, 2026 (in effect)GeorgiaThe container THC disclosure is a milligram amount, not a percentage. SB 220, enacted as Act 712 and effective July 1, 2026, struck "percentage" from O.C.G.A. 16-12-191(a)(1) and inserted "amount of milligrams". This hub described the change as mid-flight and told buyers to print both figures to satisfy either version; the percentage requirement no longer exists. The 1,200 mg per individual package ceiling is confirmed in the enacted text at 16-12-200(15), where this hub had it only from the Commission's FAQ page and flagged it as unconfirmed. Food products containing medical cannabis, cookies, candies and edibles, are excluded from the definition of Product by name at 16-12-200(15)(B). source ➞ In Effect

July 1, 2026 (in effect)GeorgiaVaporization age corrected. O.C.G.A. 16-12-234(a)(2) as amended makes it unlawful to ingest by vaporization "by any individual 21 years of age or younger", so the permitted age begins at 22. This hub's recommended label line read "For use by registered patients 21 and older", which understates the limit, and the rules sections described the restriction the same way. Separately, the January 1, 2027 deadline in SB 220 sits at 16-12-234(b) and runs to the Department of Public Health for rules on methods of ingestion; this hub attributed it to the Commission as a deadline for final labeling and packaging rules. source ➞ In Effect

Proposed; adoption vote scheduled September 30, 2026GeorgiaGMCC has noticed a rewrite of Rule 351-4-.07 that would prescribe warning sentences word for word for the first time. Georgia currently prescribes none. The proposal retitles the rule "Product Registration; Packaging and Labeling", splits the product label from a new safety label and a new tracking label, and would add a crime-of-transfer statement to the product label plus seven safety-label warning statements and an inhalable-product age statement. Written comments close at 5:00 p.m. ET on September 9, 2026, the in-person public hearing is September 16, 2026, and the Commission votes on adoption at a virtual meeting on September 30, 2026. Nothing from the proposal is published on this hub as a requirement, and none of its wording should be set into type before adoption. source ➞ Upcoming

June 14, 2026 (in effect)AlabamaTwo required label elements were missing and two published ones do not exist. Ala. Admin. Code r. 538-X-6-.05(2)(e) requires the name AND license identification number of the Cultivator on the Processor label, which this hub carried only as content sitting behind the QR code, and (2)(f) requires the Processor's license identification number alongside its name. Paragraph (2)(d) asks for lot AND batch numbers, where this hub listed the batch number alone. Against that, this hub listed processing and packaging dates and harvest information as printed label elements: the dates belong to the behind-the-code list at (2)(o)(4) and harvest information appears nowhere in the rule. source ➞ In Effect

June 14, 2026 (in effect)AlabamaThe universal state symbol is now published in the rule. The amendment effective June 14, 2026 incorporates the symbol the Commission approved on January 26, 2026 as Appendix A to Chapter 538-X-6, alongside the new principal-display-panel placement. This hub said AMCC published no artwork or specification sheet and told buyers to request it. Two additions to the attractive-to-minors list at r. 538-X-6-.02(1) were also missing here: packaging shaped like a non-cannabis consumer product commonly marketed to minors, and celebrities whose audience is more than 15% minors. The peach flavor rule at r. 538-X-6-.04(2)(e) covers gelatinous cube, cuboid and lozenge products, not gummies alone. source ➞ In Effect

January 1, 2026 (in effect)OregonOAR 845-025-7030 re-read at the Oregon Secretary of State's rules database, current through OLCC 6-2025 (effective January 1, 2026). Three corrections: the hemp symbol floor is codified at 0.48 in by 0.35 in, where this hub had said no hemp size was published; the symbols may be enlarged, since the rule bars modification 'other than the size'; and the January 2026 nutrition information format is codified at (19)(b) rather than resting on a compliance bulletin. Layout requirements previously unpublished were added, including the net quantity declaration in bold in the bottom 30 per cent of the principal display panel, set apart on all sides by a space equal to its own lettering height. source ➞ In Effect

August 1, 2026 (in effect); ratio hemp-infused products January 1, 2027MinnesotaThe 2026 omnibus is 2026 Minn. Laws ch. 123 (SF 4401), replacing this hub's HF4203 / SF4401 reference. Two unverified potency figures were withdrawn: a 200 mg per-package edible cap, which appears nowhere in the Office of Cannabis Management's own summary of the act, and a 100 mg per-serving figure attributed to a new Ratio Hemp-Infused category, which is in fact the long-standing lower-potency hemp edible ceiling at Minn. Stat. 342.01, subd. 50(b)(1). Newly published: multi-serving hemp beverages of at least 750 ml at 5 mg THC per serving to a maximum of 17 servings, off-site sale only; hemp-derived topicals containing THC must say so; and hemp topicals may now reach 0.3 per cent THC. source ➞ In Effect

July 1, 2026 (in effect)MontanaAll four warning statements at 16-12-215(1), MCA re-confirmed character for character against the codified text at mca.legmt.gov, along with the poster and exit-package requirements. The typography rule — a legible font such as Times New Roman, Arial or Helvetica with the lowercase o at least one-sixteenth inch high — is carried by the statute itself as amended by HB 792, not only by ARM 42.39.314, which matters because rules.mt.gov again returned HTTP 405 on every route including the site root. No conforming ARM amendment has been located; the Department's only 2026 adoption notice amends the testing rules. The Department's own Labeling and Packaging page still displayed the superseded three-warning set on September 1, 2026. source ➞ In Effect

Adopted 7/23/2026; not yet effectiveNevadaLCB File No. R152-24 was adopted by the Board and posted as an Adopted Regulation on July 23, 2026. It is not yet approved by the Legislative Commission, so it is not effective. Once it lands it extends the bold identifier block to every product, shortens the edible delayed-onset warning, drops two statements from the flower label and repeals the irradiation notice. source ➞ Upcoming

January 15, 2026 (in effect)OhioThe universal THC symbol and the Division of Cannabis Control seal reach packaging through OAC 1301:18-4-22(H) and (I), which apply to an advertisement on or depicting a container capable of storing cannabis. No package-level minimum size is codified; the quarter-inch figure belongs to the medical edible portion rule at 3796:3-2-02(B)(3). OAC 1301:18-4-04 does not exist, so the Rule Package 6B proposal remains unadopted. source ➞ In Effect

July 1, 2026 (in effect)ArizonaA.R.S. 36-2859 as amended by Laws 2025, Ch. 166 took effect July 1, 2026. The advertising warning prints black on white and takes at least ten percent of the advertising area, with a type-size alternative for billboards. Advertising may not state potency or THC levels. The section is enforced by the attorney general, and the $20,000 civil penalty reaches only non-licensees; a licensee gets fourteen days to comply and then ADHS disciplinary action. source ➞ In Effect

January 1, 2026UtahNew pregnancy/breastfeeding warning statement added to required label language. source ➞ In Effect

November 1, 2026 (anticipated)VirginiaAdult-use retail market framework advancing — retail sales may begin November 1, 2026. [SUPERSEDED — retail sales now July 1, 2027 under the amended compromise.] CCA drafting packaging/labeling regulations. source ➞ Upcoming

January 1, 2026OregonModern nutrition label templates required on marijuana and hemp edible labels effective January 1, 2026. Address requirement removed for non-edible inhalable labels. source ➞ In Effect

January 1, 2026OregonHemp Product Registry (HB 4121) effective January 1, 2026; OLCC compliance enforcement begins June 1, 2026. EPR program fees due July 1, 2026. source ➞ In Effect

2026 (pending)West VirginiaHB 5260 passed House March 2026: would allow edible THC products from dispensaries (pending Senate/Governor). source ➞ Upcoming

April 2026 (anticipated)AlabamaFirst dispensary sales expected late April/early May 2026. Three dispensary licenses awarded December 2025 (CCS of Alabama, GP6 Wellness, RJK Holdings). source ➞ Upcoming

2026 (pending)GeorgiaSB 220 passed House March 2026 (138-21 vote): replaces 5% THC potency cap with 12,000 mg possession limit; adds vaporization delivery for patients 21+; adds lupus, severe arthritis, severe insomnia to qualifying conditions. Awaits Senate concurrence. source ➞ Upcoming

2026 (proposed)MichiganCRA proposed rulemaking: serving size identification on products, single-serving packaging or scoring/measuring device for edibles, labeling requirements extended to inner AND outer packaging. source ➞ Upcoming

2026ConnecticutWhite-labeling flexibility: sub-brand logos permitted without separate DBA registration. Retailers may open packaging for locked display cases (max 1 lb, 'FOR DISPLAY ONLY' sticker required). source ➞ In Effect

January 2026FloridaEmergency Rule 64ER25-5 (January 2026): delivery device recall provisions and packaging requirements. Emergency Rule 64ER25-6: MMTC advertising/marketing requirements including outside signage and internet criteria. source ➞ In Effect

August 2026 / January 1, 2026CaliforniaDCC implementing rubric for prohibited child-attractive packaging by August 2026. Animal cannabis product regulations (AB 1885) effective January 1, 2026. source ➞ In Effect

2026WashingtonSB 6303: cannabis vapor products must use removable batteries for recycling/disposal. Retailers may accept used vapor devices and batteries for recycling. LCB denied petitions to amend WAC 314-55-095/105. source ➞ In Effect

January 1, 2026HawaiiAct 269 hemp retail registration requirement effective January 1, 2026. All hemp businesses must register with OMCCR. Grace period before enforcement begins. source ➞ In Effect

Mid-May 2026 (Governor decision pending)GeorgiaSB 220 ('Putting Georgia’s Patients First Act') enrolled and sent to Governor Kemp on April 10, 2026 after Senate concurrence (144-21 bipartisan). Governor has 40 days from sine die (April 2, 2026) to act — final decision expected by mid-May 2026. If enacted, replaces 5% THC potency cap with 12,000 mg THC possession limit, allows vaporization for patients 21+, and adds lupus, severe arthritis, and severe insomnia to qualifying conditions. source ➞ Upcoming

April 14, 2026 (budget vote only)PennsylvaniaPA House passed Governor Shapiro’s FY budget on April 14, 2026 (107-94), which assumes ~$729.4M in adult-use cannabis tax revenue, but the budget itself does NOT legalize adult-use. Republican-controlled Senate remains opposed; HB 1200 adult-use legalization bill still pending. No packaging/labeling rule changes; medical program (28 Pa. Code §1151a.34) unchanged. source ➞ Upcoming

2026 (legalization stalled)New HampshireHB 186 adult-use legalization bill tabled by NH Senate (all but one Republican voted to table) in early 2026. Recreational cannabis remains illegal in NH; medical-only program continues with no packaging/labeling changes. source ➞ Upcoming

May 11, 2026 (MOAHR approval; JCAR filing pending)MichiganMOAHR approved CRA proposed marijuana rules on May 11, 2026 — final substantive review step before legislative filing. Labeling provisions are being restructured into R 420.405–420.405b. Key adopted provisions: serving-size identification on products; single-serving packaging OR scoring/measuring device for edibles; labeling requirements extended to BOTH inner AND outer packaging. Next step: JCAR filing. source ➞ Upcoming

May 13, 2026 (proposed rule; comment/adoption pending)FloridaNotice of Proposed Rule 64-4.219 (MMTC Packaging and Labeling) published in the Florida Administrative Register on May 13, 2026 (Vol. 52 No. 93). The proposed nonemergency rule will REPLACE Emergency Rules 64ER20-32, 64ER20-35, and 64ER22-2 and provide a durable packaging/labeling standard, refining label content, required warnings, and the alignment between product labels and laboratory Certificates of Analysis. Initiated pursuant to Chapter 2025-199, § 15, Laws of Florida. source ➞ Upcoming

May 26, 2026 (macrobusiness license effective Jan 1, 2027)MinnesotaThe 2026 Cannabis Omnibus Bill was signed May 26, 2026 and is enacted as 2026 Minn. Laws ch. 123 (SF 4401). Provisions that reach a package: a new 'Ratio Hemp-Infused Cannabis Product' category for low-potency licensees, balanced with non-intoxicating secondary cannabinoids; the merger of Minnesota's bifurcated medical and adult-use supply chains, so a medical endorsement lets one business serve patients and adult-use customers; and a new 'macrobusiness' licence category from January 1, 2027. Two milligram figures previously published in this entry — a 200 mg per-package edible cap and 100 mg of secondary cannabinoids per serving for the ratio category — have been withdrawn. Neither appears in OCM's own summary of the act, and the Minnesota page carries no per-package figure for adult-use edible cannabis products for the same reason. Ratio hemp-infused products do not exist until January 1, 2027 and no per-serving or per-package figure has been published for them. source ➞ In Effect

Revised: regs/apps due September 1, 2026; retail sales July 1, 2027VirginiaCCA confirms accelerated adult-use retail launch timeline (May 2026): license application portal opens July 1, 2026; up to 100 temporary direct-to-consumer microbusiness licenses to be issued by September 1, 2026 (cultivate/process only until retail starts); full adult-use retail sales commence November 1, 2026 — earlier than the prior January 1, 2027 target. Standard retail licenses capped at 350 statewide. CCA deadline to finalize packaging/labeling regs remains September 1, 2026. [SUPERSEDED July 2026: the enacted amendment compromise moved full retail sales to July 1, 2027; regs and application window still due September 1, 2026.] source ➞ Upcoming

May 19, 2026 (CCC appointment deadline)MassachusettsH.5350 implementation update (May 2026): Governor Healey faced a May 19, 2026 statutory deadline to appoint the new 3-person CCC under the restructured commission (1 social-justice member + 2 with expertise spanning social justice, public health, public safety, business regulation, consumer commodities, and/or marijuana production/distribution). Until CCC promulgates equivalency regulations, retailers may not knowingly sell more than 2 oz of marijuana (or its combined dry-weight equivalent in concentrate or edibles) to a single customer per day. Equivalency rulemaking in progress. source ➞ In Effect

June 3, 2026 (transition end / enforcement begins)New YorkPLMA Part 128 transition period ENDS June 3, 2026 (no extension announced as of June 1, 2026). OCM enforcement of QR codes to CoA, rotating health warnings, allergen/ingredient disclosures, 6-pt minimum font, retail-packaging standards, exit-packaging standards, and display-panel information begins June 3, 2026. Section 128.10 identifies the specific provisions subject to delayed enforcement; all other PLMA requirements have been enforceable since December 3, 2025. source ➞ In Effect

June 1, 2026 (enforcement begins)OregonOLCC Hemp Product Registry compliance-action enforcement BEGINS June 1, 2026 (no extension announced as of June 1, 2026). All hemp items subject to the registry requirements must be properly registered and labeled per registry rules. Sales of unregistered hemp items must be discontinued. OLCC may still pursue violations involving sales to minors, exceeding THC limits, or intoxicating artificially derived cannabinoids regardless of registry status. source ➞ In Effect

Hearing concluded July 15, 2026; post-hearing briefs due August 17, 2026FederalFollow-on to April 23, 2026 DOJ/DEA Schedule III rescheduling order: DEA administrative hearing on BROADER rescheduling of ALL marijuana (not just FDA-approved + qualifying state medical) from Schedule I to Schedule III begins June 29, 2026. State-licensed cannabis operators' state packaging/labeling obligations are unchanged in the interim; DEA-registered medical operators continue to operate under §825(c) statutory-warning-label reliance pending final outcome. [UPDATE Aug 2026: hearing concluded on schedule July 15, 2026; the ALJ ordered post-hearing briefs/closing arguments (max 50 pages) due August 17, 2026, with a recommended decision to follow — no timeline announced. A lawsuit challenging the April 2026 rescheduling order has been filed; no injunction reported.] source ➞ In Effect

June 8, 2026 (CPIA launched)CaliforniaDCC launched the Cannabis Product Image Analyzer (CPIA) — an AI tool (beta) that assesses whether packaging/labeling is 'attractive to children' under 4 CCR 15040(a)(2) and (a)(3)(A)-(D). Followed the August 2025 State Auditor report urging stronger DCC packaging oversight. AB 2249 (standardized 'attractive to children' rubric + written-determination process) continued advancing in the Legislature. A favorable CPIA result is advisory, not a binding safe-harbor determination. source ➞ In Effect

October 1, 2026 (Public Act 26-8; signed May 4, 2026)ConnecticutHB 5350 enacted as Public Act 26-8 (signed May 4, 2026; provisions effective October 1, 2026). Infused-beverage limits rise to up to 5 mg total THC/container (package/liquor-permit channels) and up to 10 mg total THC/container (cannabis retailers) with plus/minus 10% lab variance; a new 'high-THC beverage' class is defined and restricted to out-of-state sales. Potency caps removed for concentrates/other non-flower material (flower cap stays 35%, other products 70%). High-potency products require additional disclosure/warnings and standardized 'chemotype' (THC-to-CBD ratio) labeling. Packaging strengthened: child-resistant, tamper-evident, opaque, plus detailed cannabinoid/ingredient/warning/tracking labeling. source ➞ Upcoming

Second hearing held July 23, 2026; comments closed July 24, 2026; JCAR filing next (none as of Aug 1, 2026)MichiganPost-MOAHR (May 11, 2026) update: the CRA announced a SECOND public comment period and hearing that will occur BEFORE any JCAR filing, delaying final adoption of the marijuana rule package (including the R 420.405-420.405b labeling restructuring — serving-size identification, single-serving/measuring-device requirement for edibles, and inner-and-outer package labeling). source ➞ Upcoming

June 10, 2026 (repeal signed); injunction-lift motion June 29, 2026Rhode IslandResidency-requirement litigation: a U.S. District Court preliminary injunction (April 8, 2026) halted RICCC's retail-license lottery/application review after out-of-state applicants challenged the Cannabis Act's 51% in-state residency requirement; RICCC appealed April 14, 2026. Governor McKee signed a pair of bills on June 10, 2026 eliminating the residency requirement, voiding the original application process, and directing a new one; on June 29, 2026 the state moved to lift the court order so licensing can resume. [UPDATE Aug 2026: in a late-July 2026 order Judge DuBose signaled she will dissolve the injunction; the reset lottery could occur as early as August 2026.] Packaging/labeling rules unchanged; timing of new-retailer onboarding affected. source ➞ In Effect

2026 session (SB 120 pending)PennsylvaniaAdult-use status (2026 session): HB 1200 (state-store model) was rejected by the Senate Law & Justice Committee (7-3) on May 13, 2025 and not revived; the current vehicle is SB 120 (Sens. Laughlin & Street), a private-retail model creating a Pennsylvania Cannabis Control Board with a 14% combined tax — not yet enacted. Pennsylvania remains medical-only; no packaging/labeling rule changes this cycle. source ➞ Upcoming

Sept 10, 2026 (medical fed warning); Nov 1, 2026 (label deadline)IllinoisIDOA Spring 2026 rule update (JCAR-approved April 14, 2026): by November 1, 2026 labels must list 'Total THC' (THC + 0.877 x THCA per COA), all COA cannabinoids above 0.3% by weight or 0.4 mg, and disclose hemp inputs (Metrc-tracked CBD/CBG/THCV/CBN isolates only). Separately, SB 3222 / Public Act 104-0463 (signed June 12, 2026) requires a federally mandated warning label on all products sold to medical patients as of September 10, 2026. source ➞ Upcoming

Regs/apps due Sept 1, 2026; hemp cap Aug 15, 2026; retail July 1, 2027VirginiaRetail timeline revised: enacted compromise (after Governor Spanberger's April 2026 amendments to HB 642/SB 542) sets full adult-use retail sales at July 1, 2027; CCA must promulgate adult-use packaging/labeling regulations and open the application window by September 1, 2026. Hemp regulation transfers from VDACS to CCA (~Aug 2026); effective August 15, 2026 no hemp product over 2 mg total THC/package (25:1 ratio exception eliminated); SB 543 requires an official CCA retailer decal. source ➞ Upcoming

July 1, 2026 (in effect)GeorgiaSB 220 ('Putting Georgia's Patients First Act') provisions took effect July 1, 2026: 'medical cannabis' rename, 12,000 mg possession ceiling, vaporization for patients 21+, and a new 1,200 mg THC per-package cap. GMCC final testing/labeling/packaging rules for new product types due by January 1, 2027. source ➞ In Effect

July 1, 2026 - January 1, 2027 (transition window)UtahProgram transfer to UDAF underway (HB 389/SB 121): the medical cannabis program moves from the DHHS Center for Medical Cannabis to the Utah Dept. of Agriculture and Food, with duties movable from July 1, 2026 and the transfer required to be complete by January 1, 2027. The department says providers, patients and industry will be told once it is done; no completion announcement had been published as of September 1, 2026. UDAF is already issuing both processor and pharmacy bulletins. The authority to regulate label language describing a physiological effect was written into statute at 4-41a-602(6)(c) effective May 6, 2026. source ➞ In Effect

July 1, 2026 (in effect)ArizonaHB 2179 advertising restrictions in effect: mandatory warning ('Do not use marijuana if you are under twenty-one years of age or pregnant. Keep marijuana out of reach of children.') on at least 10% of ad space; child-appealing imagery banned; location/audience restrictions. Advertising-side; on-package rules unchanged. source ➞ In Effect

Emergency regs (summer 2026); permanent adoption pendingMassachusettsCCC adopted emergency amendments to 935 CMR 500 implementing Ch. 65 (retail license cap 3 to 6; daily purchase limit 2 oz), temporarily effective three months; written comment July 3-30, 2026; public hearing July 30, 2026. Potency-label audits ongoing (labeled potency must be within 75-125% of tested values). Conversion-standards rulemaking still pending. source ➞ In Effect

Signed July 23, 2026; effective October 21, 2026 and February 1, 2027DelawareHB 373, the hemp-derived THC-infused beverage framework, was signed July 23, 2026 with effective dates of October 21, 2026 and February 1, 2027. It is separate from the marijuana beverage rules, which already exist at 4 DE Admin. Code 5001-8.3.1.2 and 9.3.2 and are unaffected. What it does change for marijuana is the statutory ceiling on the Commissioner: effective October 21, 2026 the 10-serving limit at 4 Del. C. 1331(13)c is replaced by 10 mg of total THC per serving and 100 mg in a multi-serving package, and a new (13)n sets infused-beverage serving limits of 10 mg per single-serving container, 60 mg per multi-container package and 170 mg per 750 ml bottle. Ceilings on rulemaking are not package limits - nothing a buyer prints changes on that date unless OMC amends Section 8.3 or 9.3. source ➞ Upcoming

July 31, 2026 (reporting); litigation pendingColoradoEPR program: July 31, 2026 supply-data reporting deadline to Circular Action Alliance for obligated producers (incl. cannabis/hemp-beverage packaging). July 30, 2026: National Association of Wholesaler-Distributors filed a federal lawsuit challenging the HB22-1355 Producer Responsibility Program; no injunction — obligations unaffected. source ➞ In Effect

July 1, 2026 (in effect)HawaiiDOH/OMCCR and the Attorney General began enforcing Act 269 (2025) hemp retailer/distributor registration July 1, 2026 (grace period ended June 30); enforcement covers product forms, cannabinoid limits, testing, and labeling/packaging; DOH may seize noncompliant or mislabeled THC products. source ➞ In Effect

July 1, 2026 (in effect)KentuckyEffective July 1, 2026 cardholders purchasing cannabis out-of-state lost conditional-pardon protection (EO 2022-798); only Kentucky-dispensary product bearing the standardized navy-blue Kentucky symbol (915 KAR 1:100, Appendix A) is protected. Label rule text unchanged. source ➞ In Effect

July 1-3, 2026 (in effect)WashingtonESB 5206 cannabis retail advertising rule (WAC 314-55-155) effective July 3, 2026; EHB 2681 license-fee rule effective July 1, 2026. Harvest-date labeling remains at CR-101 preproposal; core packaging rules (WAC 314-55-095/-105) unchanged (amendment petitions denied). source ➞ In Effect

January 1, 2026 (in effect)CaliforniaAnimal cannabis product standards (4 CCR 17350, adopted via DCC-2025-02-R implementing AB 1885; OAL approval November 24, 2025) limit animal cannabis products to edibles, orally consumed concentrates and topicals, and cap them at 1 milligram of Total THC per package. All other packaging and labeling requirements apply to them unchanged. source ➞ In Effect

June 12, 2026 (in effect)IllinoisThe universal warning statement required on every cannabis package changed with P.A. 104-463. As codified at 410 ILCS 705/55-21(i) and 8 Ill. Adm. Code 1300.940(b)(1), it now closes 'Possession or use of this product may carry significant legal penalties in some jurisdictions and under federal law.' The two FDA sentences carried on many existing plates appear in neither the statute nor the rule. source ➞ In Effect

May 1, 2026 (in effect; November 1, 2026 implementation date)IllinoisTotal THC (THC + 0.877 x THCA), a list of every other cannabinoid on the COA above 0.3% by weight or 0.4 mg, and an indication that a product contains hemp became codified label elements at 8 Ill. Adm. Code 1300.930(b)(8), amended at 50 Ill. Reg. 7050 effective May 1, 2026. The Department's Spring 2026 bulletin gives licensees until November 1, 2026 to get them onto labels — an implementation date, not the date the requirement begins. The same amendment carries 1300.930(b)(9), requiring directions in legible Spanish giving access to the labeling information by electronic link or other medium. source ➞ In Effect

June 12, 2026 (in effect)IllinoisNew 410 ILCS 705/55-22 requires a warning label targeted to medical patients, affixed by the dispensing organization to the outside of the product before it is dispensed. The statute prescribes no wording — it must be the same as or substantially similar to language required for the same purpose under federal law — and it may not cover or restrict anything Section 55-21 requires. It is a dispensary-applied label, not a printed packaging element. September 10, 2026, the date IDFPR groups it under, is the medical dispensary licence opt-in date at 410 ILCS 705/15-37. source ➞ In Effect

June 18, 2026 (in effect)MassachusettsThe Commission publishes a codified 935 CMR 500.000 effective June 18, 2026, listed as both current and emergency, carrying the licence cap and daily purchase limit changes from Ch. 65 of the Acts of 2026. No packaging or labeling figure moved. Read against it, the four label warning statements at 500.105(5) are confirmed, and Marijuana Vaporizer Devices carry a terpene-source statement at 500.105(5)(c)7.b.-c. that sits in the ingredient list rather than the warning list. source ➞ In Effect

August 24, 2026 (in effect)FloridaRule 64-4.219 (MMTC Packaging and Labeling) is in effect, and the adopted text has now been read in full. It fixes the universal symbol at a quarter inch square on every receptacle and at no less than 10 percent of overall surface area on the package; scopes resealability to multiple-use products and multi-serving edibles rather than to every receptacle; and bans neon colours only. Previously approved non-conforming packaging cannot be dispensed after about 20 February 2027. Rule 64-4.218 (MMTC Trade Name and Logo) was still not adopted as of 1 September 2026. source ➞ In Effect

January 7, 2026 (rules); May 6, 2026 (statute)UtahThe replacement R66-2 has now been read in full and every Utah citation on this hub is re-cut against it. Labeling and packaging is R66-2-13; the section this hub cited in prior cycles, R66-2-15, is now Change in Operation Plans and has nothing to do with labels. Two things published here as rule requirements are not in the rule as it now reads and have been removed: a 20 percent ceiling on the area a logo and brand name may occupy on the product face, and a requirement that the descriptive product name be set smaller than the dosage form. The rewrite also dropped child-resistance, tamper-evidence and the 21 CFR 111 packaging-and-labeling reference from the rule entirely, leaving those duties to Utah Code 4-41a-602(1)(b). The prescribed sentence 'This product contains artificially derived cannabinoids.' survives the rewrite word for word at R66-2-13(12) and is again shown as mandated wording rather than unverified. Separately, 4-41a-602 was amended effective May 6, 2026 by Chapter 421 of the 2026 General Session: label, logo, brand name and packaging pre-approval, the flavor/terpene/cultivar-only change carve-out, and the allowance for the word hash in a product name all moved from rule into statute, the rulemaking subsection moved from (5) to (6), and a new (6)(c) lets the department regulate label language describing a physiological effect. source ➞ In Effect

January 20, 2026 (in effect)LouisianaLAC 51:XXIX.2507 was read in full from the Louisiana Register rather than a law publisher, and every figure this hub publishes for Louisiana survives verification unchanged. Section 2507.E requires tightly-sealed and light-impermeable packaging; 2507.H sets the nine label elements exactly as listed here; there is no warning statement, no symbol, no child-resistant requirement and no maximum container size anywhere in the Part. One refinement: both duties sit in Subpart 2, Marijuana Retailers, and Subpart 1, Marijuana Manufacturers, contains no packaging or labeling provision at all - so the container specification binds the retailer at the point of issue, though a supplier who ships anything else has sold a package the retailer cannot use. source ➞ In Effect

December 3, 2025New YorkPLMA regulation overhaul: updated warning statements, QR codes to CoA, rotating health warnings, allergen/ingredient disclosures, 6-pt min font. Transition period ends June 3, 2026. source ➞ In Effect

November 1, 2025OklahomaNew required warning language: driving impairment, pregnancy/breastfeeding, and contaminant testing statements added to label requirements. source ➞ In Effect

October 1, 2025ConnecticutTHC potency limits raised (flower 35%, non-vape 70%) effective October 1, 2025. New 'High THC' label segments required on menus and packaging. source ➞ In Effect

August 1, 2025DelawareAdult-use cannabis market launched; sales began August 1, 2025. source ➞ In Effect

August 1, 2025North DakotaHB 1203: edible medical cannabis (square lozenges only, 5 mg/serving, 50 mg/package) legalized effective August 1, 2025. Same CR/tamper-evident packaging standards apply. source ➞ In Effect

July 15, 2025VermontLabel color palette rule amended effective July 15, 2025. Prior color palette labels may be used until January 1, 2027. Plastic packaging remains prohibited. source ➞ In Effect

July 1, 2025MarylandEffective July 1, 2025: ALL THC products (Delta-8, -9, -10) must meet MCA packaging/labeling standards including symbol, CoA QR, and child-resistant packaging. source ➞ In Effect

June 1, 2025OklahomaPre-pack requirement: all flower-based products must be pre-packaged before dispensary transfer (SB 518). source ➞ In Effect

May 1, 2025Rhode IslandNew cannabis regulations approved; packaging/labeling rules effective. source ➞ In Effect

April 19, 2025AlaskaLabeling amendment effective April 19, 2025: wholesale shipping labels must list all additional contaminants tested beyond minimum requirements. source ➞ In Effect

February 2025New JerseyFebruary 2025 CRC packaging addendum: inactive/excipient ingredient listing required on package; CBG and CBN disclosure encouraged. source ➞ In Effect

November 17, 2025 compilation (in effect)HawaiiChild-resistant scope corrected, and it is the widest reading, not the narrowest. HAR 11-850-142(a)(1) requires child-resistant special packaging on every package of cannabis and of manufactured cannabis product, to 16 C.F.R. part 1700 as published as of January 1, 2021, certified for the number of openings and closings customary for that package size and contents. This hub previously limited the requirement to multi-serving edible packages and carried no Hawaii citation at all, so a flower jar or a single-serving pack built from this page could have shipped without a child-resistant closure. source ➞ In Effect

November 17, 2025 compilation (in effect)HawaiiResealability requirement withdrawn as unfounded. This hub published a multi-serving resealability mandate with an empty citation and a standing request to find one. The word does not appear anywhere in HAR Chapter 11-850. What Hawaii actually requires on a multi-serving edible is a portioning aid under 11-850-76(g): single-serving packaging, scoring that guides breaking into single servings, or an included measuring device marked for a single serving. That is a pack-format decision, and it was not published here before. Tinctures are separately capped at a two-ounce maximum volume and must be labeled for use in drops or dropperfuls, 11-850-76(b)(6). source ➞ In Effect

May 8, 2025 filing (in effect)West VirginiaCitations corrected and a design prohibition restored. The grower/processor label items at W. Va. Code R. 64-110-16.4 are numbered subdivisions, 16.4.1 through 16.4.16, not lettered: the verbatim warning is 16.4.14, the original-container warning 16.4.15 and the unauthorized-use warning 16.4.16, where this hub cited 16.4.n, .4.o and .4.p. Rule 16.5.4 also prohibits any cartoon, COLOUR SCHEME, image, graphic or feature that might make the package attractive to children; the colour-scheme clause was not published here, and a palette alone can fail the rule with no image on the pack. The statutory warning statement at W. Va. Code 16A-8-1(h)(4) was re-read from the Legislature's own copy and holds word for word. source ➞ In Effect

August 28, 2025 (in effect)OhioOAC 1301:18-4-09(A) bars a cultivator or processor from packaging a product without prior written Division approval, so adult-use artwork sits behind a product registration. OAC 1301:18-4-08(A)(6) separately bars any departure from the registered product name, including slang terms. source ➞ In Effect

January 7, 2025 (in effect)WashingtonEvery WAC 314-55-105 warning string was transcribed character for character from the official WAC PDF certified 1/8/2025 and is now published as verbatim. The habit-forming statement uses a hyphen for concentrates and solid edibles and an en dash for liquid edibles, useable cannabis and cannabis mix; the split had been carried as unresolved. The statements close with a semicolon inside the quotation marks, and "Warning" takes no colon. source ➞ In Effect

January 7, 2025 (in effect)WashingtonTwo required statements were missing: the edible delayed-effects caution at (3)(h)(v) and (4)(g)(v), and the smoking warning on cannabis concentrates at (2)(g)(v), which had been scoped to flower only. Topicals carry the out-of-state statement at (7)(f)(i), and DO NOT EAT must be set in bold capital letters. source ➞ In Effect

January 7, 2025 (in effect)WashingtonChild-resistant packaging under WAC 314-55-105 reaches concentrates and edibles in solid and liquid form only, and offers two alternative routes: 16 C.F.R. Part 1700 packaging, or two-mil heat-sealed plastic with no easy-open feature. Useable cannabis, cannabis mix and topicals carry no child-resistance requirement in that section. Liquid edibles need a measuring device, and hash marks on the package or cap qualify. source ➞ In Effect

January 1, 2025LouisianaRegulatory authority for medical cannabis packaging transitioned from Board of Pharmacy to Louisiana Department of Health. source ➞ In Effect

2025NevadaSB 168 and AB 76 enacted: revised packaging/labeling sections moved into NRS; new infused pre-roll category; anthropomorphic imagery explicitly banned. source ➞ In Effect

2025MontanaUpdated warning statements must be placed next to universal symbol; addiction resource link required on all exit packaging. Single serving now 5 mg THC (signed May 8, 2025). source ➞ In Effect

2025 (proposed; not adopted)New MexicoCCD proposed 2025 rulemaking (hearing September 3, 2025): retail license number on principal display label; all products in opaque, resealable, CR containers; deletion of the exit-packaging section; 'Remediated' label for microbial-remediated products. Still not adopted as of September 1, 2026 — the codified part carries only its 04/01/2022 filing and the exit-packaging section is intact. Nothing here is a requirement yet. source ➞ Upcoming

July 1, 2025 / January 1, 2026MinnesotaEPR registration required by July 1, 2025 (Circular Action Alliance). OCM-licensed testing labs mandatory January 1, 2026. source ➞ In Effect

May 2025 (dispensary-name element superseded June 12, 2026)IllinoisCROO Packaging FAQ released May 2025: BioTrack-to-Metrc transition guidance — pre-labeled BioTrack products do not need relabeling. The FAQ also allowed the manufacturer to add the dispensary name; that element is no longer required at all, since P.A. 104-463 struck 410 ILCS 705/15-70(b) on June 12, 2026. source ➞ In Effect

2025-2026NevadaCCB amendments: individual edible servings (medical) must be stamped/molded with universal symbol; irradiation packaging statement repealed; anthropomorphic imagery explicitly prohibited; standardized compliance checklists in development. source ➞ In Effect

May 13, 2025 (HB 1200 stopped in Senate L&J)PennsylvaniaCORRECTION TO PRIOR AUDIT: HB 1200 ('Cannabis Health & Safety Act') was previously characterized as 'still pending Senate' — re-verified status: the Senate Law & Justice Committee rejected/tabled HB 1200 by a 7-3 vote on May 13, 2025, ending its progress for the 2025-2026 session. No replacement adult-use legalization bill has cleared either chamber as of June 1, 2026. Governor Shapiro's FY budget (passed PA House April 14, 2026 assuming ~$729.4M in adult-use cannabis tax revenue) does NOT itself legalize adult-use. PA medical-only program (28 Pa. Code §1151a.34) unchanged. source ➞ Upcoming

September 11, 2025 (in effect)DelawarePackage and serving limits corrected and completed. The edible package cap this hub published as 10 servings is the ceiling 4 Del. C. 1331(13)c sets on the Commissioner's rulemaking, not a limit a package may be built to; the operative rule at 4 DE Admin. Code 5001-8.3.1.1 caps an edible package at 5 standardized servings. Three specifications never published here are in force: marijuana beverage packages are capped at 60 mg THC and a beverage serving must be at least 12 ounces of liquid (both adopted at 29 DE Reg. 221 and effective September 11, 2025), and tincture packages are capped at 300 mg THC. Section 8.2.4 also requires each standardized serving to be physically demarcated or packaged so a buyer can identify it, to be easily separable with minimal effort, and to contain the same amount of THC as every other serving in the package. Note that the consolidated Administrative Code copy regulations.delaware.gov currently serves predates the September 2025 order and still shows 50 mg with no volume minimum. source ➞ In Effect

December 6, 2024 amendment, compiled November 17, 2025 (in effect)HawaiiAll eight required warnings, the two required phrases, the manufactured-product statement and the external-use statement are now confirmed against the Department of Health's own compilation of Chapter 11-850 rather than a law publisher's rendering. Every string held. Terminal punctuation is settled: 11-850-143(b)(10)(A) through (G) carry no full stop inside the quotation marks and (H) does. The closing quotation mark on (F) is missing in the official text, which is a typographical slip in the rule and not a difference in wording. Section 11-850-143 was compiled, not amended, on November 17, 2025; its last substantive amendment was December 6, 2024. source ➞ In Effect

August 28, 2024 (in effect)KentuckyThe raw plant material statement is prescribed in full capitals. Section 2(2)(d)3 of 915 KAR 1:100 quotes it as "NOT INTENDED FOR CONSUMPTION BY SMOKING", with no terminal period. This hub published it in sentence case with a full stop and flagged the casing as uncertified. It is now certified against the Legislative Research Commission's copy. The label content list was also rebuilt: Section 3(2) sets seventeen items and Section 2(2) adds four package-level disclosures, where this hub previously published four of them. source ➞ In Effect

August 28, 2024 (in effect)KentuckyThe dispensary sticker is a rule, not a Royal Supply practice note. Section 3(4) requires a dispensary to affix a sticker carrying its name, license number and telephone number to each package it sells. This hub described leaving room for it as "Royal Supply practice note, not a rule". Leaving space is still the design decision; the sticker itself is mandatory, so a panel with no room for it becomes the customer's problem at retail. source ➞ In Effect

August 14, 2024 (in effect)IowaThree sets of artwork constraints published for the first time. Rule 641-154.30(1) restricts the trade name itself: it must clearly reflect the form's medical cannabidiol nature, may not be identical or similar to an existing non-medical cannabidiol product or to an unlawful product or substance, and may not suggest recreational use or use for a non-qualifying condition. Rule 154.22(1)"a" restricts the logo, barring images of cannabis or paraphernalia, colloquial references, strain or variety names, unsubstantiated medical claims and medical symbols resembling established medical associations. Rule 154.22(2)"a"(6), which 154.30(2)"b"(3) cross-references by name, sets the six-part test for appealing to children, including bubble letters and other novelty lettering and any game or activity present on the package. The allowable inhaled forms at 154.13(2)"a"(3) are nebulizable and vaporizable; this hub listed nebulizable alone. source ➞ In Effect

November 12, 2024 (in effect)ConnecticutThe codified packaging and labeling text was retrieved for the first time, from the Department of Consumer Protection's Policies and Procedures effective November 12, 2024, which C.G.S. s 21a-421j(b) gives the force and effect of law. Connecticut prescribes its warning sentences word for word, and none of the wording this hub previously published appears in the rule. Section 21a-421j-32(a)(2)(I) requires a primary warning statement outlined by a red box, plus at least one of four rotating health warnings changed quarterly; s 21a-421j-32(g)(8)-(9) puts all four rotating warnings and a prescribed yeast-and-mold statement on the extended content label. All nine statements are now published as statutory with per-subsection citations. source ➞ In Effect

November 12, 2024 (in effect)ConnecticutSymbol minimum corrected. DCP Policies & Procedures s 21a-421j-32(a)(3) requires two department-issued graphics, each not less than one-half inch by one-half inch, and s 21a-421j-32(i) adds a third at the same minimum on medical marijuana product. This hub previously published 0.5 in by 0.4366 in as a Royal Supply production standard; that height is below the codified floor, so artwork tooled from it is printing an undersized symbol. source ➞ In Effect

November 12, 2024 (in effect)ConnecticutTypography, colour and format requirements published for the first time. Label copy must be legible English in black Times New Roman, flat regular typeface, on a contrasting background, at not less than one tenth of an inch measured on a capital letter K. Packaging must be entirely and uniformly one colour, edible packaging and edible labels entirely and uniformly white, with a narrow carve-out for an uncoloured aluminium bottle or can of at least eight fluid ounces. A logo is capped at three colours and one inch square, black only on edibles, and nothing may appear on pack or label except what the section requires or permits. source ➞ In Effect

November 12, 2024 (in effect)ConnecticutResealability correction. This hub previously stated that no Connecticut resealability mandate had been verified and told buyers not to design to one. DCP Policies & Procedures s 21a-421j-31(c)(2) requires packaging for cannabis intended for multiple-serving use to be resealable in a manner that is continuously child-resistant and preserves the integrity of the contents. Edible serving and package ceilings were also published for the first time: a standard serving is 5 mg total THC, a multiple-serving package 100 mg, and a cannabis beverage may contain only one standardized serving. source ➞ In Effect

November 1, 2024 (in effect)ArizonaThe ADHS warning block was re-confirmed verbatim at A.A.C. R9-18-310(A)(2)(f) and R9-17-317(A)(6) and is unchanged. Potency disclosure was understated: the rule requires total THC, total CBD and any other cannabinoid the label makes an effects claim about. Two medical label elements were missing — the ethanol percentage at R9-17-317(A)(9)(b) and the date element at (A)(10). source ➞ In Effect

January 1, 2024MarylandQR code or URL linking to Certificate of Analysis (CoA) required on all cannabis product packaging. source ➞ In Effect

2024MinnesotaAdult-use cannabis market operational; IICPS/ASTM D8441 universal symbol adopted. source ➞ In Effect

2024OhioAdult-use cannabis market launched following passage of Issue 2. source ➞ In Effect

March 6, 2023 (in effect)New JerseyThe five consumer warning statements at N.J.A.C. 17:30-16.3(c)1 were traced and replaced a paraphrased composite block. "This product contains cannabis" and the poison control number were required and missing; a pregnancy sentence that appears nowhere in the chapter was removed. The ingestible delayed-effects statement applies to every ingestible, not only fast-acting formulations. source ➞ In Effect

March 6, 2023 (in effect)New JerseyTwo further required statements were added: the electronic smoking device FDA statement at 16.3(c)4, and the boldface two-sentence FDA disclaimer at 16.3(c)5, which is triggered by any claim about the product beyond the content the chapter prescribes. Chemotype must print as one of three prescribed phrases under 16.3(b)11i. source ➞ In Effect

July 30, 2023 (in effect)MissouriNo amendment to 19 CSR 100-1.120 as of September 2026; the codified rule still carries its original history of July 30, 2023. Two packaging requirements were under-recorded on this hub: (1)(B)4 requires all marijuana product packaging other than seeds and plants to be constructed from FDA-approved food contact substances, and both that rule and (1)(B)3 specify which container in a nested pack must comply. source ➞ In Effect

May 3, 2023 (in effect)UtahBoth lung-injury warnings go on raw cannabis and on vape cartridges, and both have been required since May 3, 2023. Utah Code 4-41a-602(1)(b)(vi) reads 'for raw cannabis or a cannabis product sold in a vaporizer cartridge ... includes a warning label that states: (A) [vaping] ... and (B) [smoke]'. The conjunction is and, so each container carries both sentences. This hub published them as a matched pair of single warnings - smoke on flower only, vaping on vape and dabbing only - and dated both to January 1, 2026. A Utah flower label built from the old page was short a required statement. The rule no longer restates these two sentences at all — R66-2 as rewritten effective January 7, 2026 leaves them to the statute — so 4-41a-602(1)(b)(vi) is the whole authority. The January 1, 2026 date belongs to the pregnancy and mental-illness sentences in the government warning, not to these two. source ➞ In Effect

Labeling rule eff. July 1, 2022; edible statute eff. August 1, 2025 (in effect)North DakotaActivation time is required on every container type, flower included. NDAC 33-44-01-26 lists it separately at (1)(a)(8) for dried leaves and flowers, (1)(b)(9) for cannabinoid concentrate and (1)(c)(10) for medical cannabinoid product. This hub cited only the product subsection and told buyers to treat flower and concentrate as out of scope until the citation could be checked. Separately, NDCC 19-24.1-24.1(3)(a) caps any cannabinoid edible product package at fifty milligrams of THC; this hub attached the 50 mg figure to edible lozenges only. source ➞ In Effect

November 1, 2018 (in effect)New HampshireHe-C 402.19 was read in full from a State of New Hampshire copy, closing every currency question this page carried. The rule's own source note reads '#10731, eff 11-25-14; ss by #12653, eff 11-1-18', so it has not been amended since November 1, 2018. The 2023 readoption (#13673-A) and the adopted rule effective October 1, 2025 (#14386) both land on He-C 402.20, Dispensing Cannabis or CIP, and neither touches 402.19. Both prescribed statements - the FDA and health-risk statement at (d)(1)j. and the therapeutic-use and diversion statement at (d)(1)k. - are confirmed word for word against the state copy, as are the allergen and residual-solvent requirements. The rule numbers its subparagraphs with lowercase letters and a full stop, so the correct citation form is (d)(1)j., not (d)(1)(j). source ➞ In Effect

Proposed; no effective date assignedWest VirginiaAmendments to both packaging rules are in the legislative rule pipeline. The Secretary of State's Code of State Rules lists an In Progress legislative version of 64-110 and of 64-112 alongside the active May 8, 2025 filings, and a modification of the proposed 64-110 was filed on August 26, 2026 following review by the Legislative Rule Making Review Committee. On the text filed so far section 16 carries forward unchanged; the change of substance is a sunset extension from August 1, 2030 to August 1, 2032. Nothing on this hub is published from the proposal. source ➞ Upcoming

In effectOregonReduced label sets separated. OAR 845-025-7030 carries two different short-label regimes that this hub had merged: the small container set at (11), for containers without room for the full label, takes one of three market-specific warnings at (11)(a)(E)(i) to (iii); the tiny container set at (12), for a labelable area under two square inches, takes only 'Keep out of reach of children.' The adult-use warning citation was corrected from (11)(a)(E)(i)-(ii) to (i), since clause (ii) is the hemp warning. The OLCC label identification number, required prominently on the outermost container by (24), was added as a label element. source ➞ In Effect

In effectMinnesotaWarning statement citations corrected. This hub cited Minn. Stat. 342.63, subds. 2(8) and 3(a)(13) for both prescribed sentences. Those subdivisions carry only 'Keep this product out of reach of children.' The out-of-state notice comes from Minn. R. 9810.1400, subp. 3, item C, which prescribes both sentences as a single warning statement in no less than size 6 font. The printed wording is unchanged and correct. The same rule also prescribes the warning symbol's colour scheme, which this hub had attributed entirely to agency guidance. source ➞ In Effect

Proposed; not adoptedMarylandThe COMAR 14.17 amendments remain proposed and unadopted as of September 1, 2026. Notice of Proposed Action 26-078-P published in Maryland Register Vol. 53, Issue 13 on June 26, 2026; comment closed July 27, 2026. The codified chapter still runs .01 to .07 with no Regulation .08, and its most recent amendment is still .03D effective April 14, 2025. The proposal would strike 'Plain and' from .02B(1)(c), add bans on anthropomorphic graphics and on sensory effects including texture, scent and sound, replace the health-benefit claim ban with a medical-or-therapeutic-claims ban, and add a sublingual pouch regulation carrying the statement 'Pouches are not intended to be heated, burned, or swallowed.' Hold Maryland artwork. source ➞ Upcoming

In effectNevadaThe retail warning statements were traced to the codified NCCR 12.040 and 12.045 and corrected. "THIS IS A MARIJUANA PRODUCT" and an FDA sentence appear nowhere in Regulation 12; the Board replaced the first with "THIS PRODUCT CONTAINS CANNABIS" in its notice of July 6, 2022. "This product may be unlawful outside of the State of Nevada" was required and missing. All statements now carry subsection citations. source ➞ In Effect

In effectNevadaNCCR 6.123 requires a Board Agent to approve packaging before an establishment may use it, and the Board allows itself up to 30 days. This hub previously stated that no pre-approval existed and that nothing gated the print run. source ➞ In Effect

In effectNevadaThe universal cannabis symbol is required on edible cannabis products only, at NCCR 12.015(1)(e) and 12.020. It appears in neither retail label list, so flower, vape, concentrate, topical and patch packs do not carry it. All label text is at least 8-point and never italic (NCCR 12.010(3)). source ➞ In Effect

In effectNew YorkAll ten Part 128 warning statements were confirmed character for character against the codified text filed December 2025 and are now published as verbatim requirements with subsection citations. The small-package label allowance at 128.5(i) does not extend to the principal display panel, the universal symbol, or two of the four universal warnings. source ➞ In Effect

In effectNew YorkThe 25 percent post-consumer recycled content rule has two written exceptions at 128.3(a)(2)(i): plastic needed to meet child resistance, and components for which no recycled-content option exists, subject to a retained due-diligence record. Part 123 adds required label elements not previously published, including expiration and use-by dates, the servings count, and a measuring device on multi-serving products that are not individually portioned. source ➞ In Effect

In effectOhioEvery mandated warning sentence in Ohio belongs to the medical program under Chapter 3796. Division 1301:18 contains no adopted packaging-and-labeling chapter, so the adult-use program mandates no warning sentence. Statements previously published as adult-use requirements were medical-chapter strings, and the two out-of-state variants distinguish two medical transfer cases rather than the two markets. source ➞ In Effect

In effectOhio"Keep out of reach of children" is not an Ohio package requirement in either program. It appears once, in the medical accompanying-material statement at OAC 3796:6-3-09(C)(4), as the second half of a longer sentence set at 12-point and never italic. source ➞ In Effect

Proposal; final adoption pendingMarylandMCA proposed amendments to COMAR 14.17 (comment closed July 27, 2026): would eliminate the plain-packaging requirement while expanding youth-appeal restrictions, create a sublingual pouch product category with its own packaging/labeling requirements, and define permissible medical/therapeutic marketing claims. NOT yet adopted. source ➞ Upcoming

Pending adoption/filingNevadaPermanent regulations R152-24 (incl. NCCR 12 packaging/labeling: capsule package limit 800 mg to 1,000 mg THC; codified anthropomorphic-image ban; irradiation-statement repeal) taken up for adoption at the June 18, 2026 CCB meeting; outcome/Legislative Commission filing unconfirmed as of August 1, 2026 — treat as pending. source ➞ Upcoming

Not in effectMichiganRule set 2023-25 LR remains unfiled with JCAR. A second public hearing was held July 23, 2026 with comments closing July 24, 2026; as of September 1, 2026 the codified rules still carry the 2020 AACS / 2022 AACS history and no renumbering has taken effect. Keep printing to R 420.403 and R 420.504 as they stand. source ➞ Upcoming

In effectColoradoRead against the Secretary of State's copy of 1 CCR 212-3, opacity in Colorado attaches only to the Exit Package, through the Rule 1-115 definition and Rule 3-1010(B)(11)(a). Neither the Container nor the Marketing Layer carries an opacity requirement, so clear containers and window cartons are compliant. The two government warning statements may sit on the Container label or the Marketing Layer; the rule sets no panel for them. source ➞ In Effect

In effectArkansasType is prescribed by rule, not by house preference. Sec. V(D)(2)(c) of the Department of Health's labeling rules requires every label to be set in Times New Roman, Helvetica or Arial at no smaller than 8 point, and (c)(i) raises two statements to an 18 point minimum: the concentrate, extract and edible patient-use line at V(C)(1)(l)(ii) and the pregnancy line at V(C)(1)(l)(iv). This hub previously published the opposite - that Arkansas prescribes no typeface and no point size, and that the 8 pt and 18 pt Arial settings were Royal Supply defaults a customer was free to change. A label set outside the named fonts, or with those two statements below 18 point, does not comply. Labels must also comply with NIST Handbook 130 (2017), incorporated by reference at V(D)(2)(b). source ➞ In Effect

In effectArkansasOpacity requirement withdrawn. This page carried an opaque-packaging requirement with no citation and an open request to find one. The word opaque appears nowhere in Section V of the Department of Health labeling rules, nor in 20 CAR 810-1301, the Commission's packaging rule. What 810-1301(a)(2)(B) requires is a container that is sealed, traceable, food compliant and child-proof, tested by the method at 16 C.F.R. 1700.20 as that section existed on January 1, 2017. Clear or windowed stock is compliant in Arkansas. Two further label elements published here as required - a Product Contains statement and an explicit Cannabis Form line reading Flower, Concentrate or Edible - appear nowhere in Section V and have been removed. source ➞ In Effect

In effectUtahTwo sentences published as prescribed edible wording are not in any Utah rule. The edible government warning here ended 'Overconsumption of cannabis may result in adverse effects. Please consult with your prescriber or pharmacist.' and was marked as text to copy exactly. Neither sentence appears in 4-41a-602 or anywhere in R66-2, and UDAF Industry Bulletin 25-03, which publishes the required statement, ends at 'recommending medical provider.' What 4-41a-602(3)(b) requires is a warning about the risks of over-consumption - content, not wording - and only on a gelatinous cube, a gelatinous rectangular cuboid, or a cube- or cuboid-shaped lozenge, not on ingestibles generally. The statutory statement is unchanged and now shown once, for every container; the over-consumption duty is a separate entry with the correct scope. source ➞ In Effect

In effectUtahThe 6 point minimum and primary-panel placement published for Utah warnings, and the 0.26 in by 0.293 in symbol minimum, are not Utah requirements. R66-2-13(1)(d) requires a department-issued warning symbol on THC-containing products, says it must contrast conspicuously with the background, and sets no dimension for it. The only codified type rule, at R66-2-13(3)(a), asks for a legible non-script, non-decorative font whose lowercase letter 'o' is at least one-sixteenth of an inch high, in a conspicuously contrasting colour; no rule names a panel. All three figures are now shown as Royal Supply production standards. Anyone who shrank artwork to exactly 0.26 in believing it was the legal floor was designing to a house number. source ➞ In Effect

In effectDelawareThe published Delaware label content list was wrong. This hub listed six elements - symbol, THC per serving and package, CBD per serving and package, serving size, manufacturing facility and batch. Section 9.2.2 sets ten: net weight, finished product batch number, the cultivating establishment for flower, the manufacturing establishment for products, the selling establishment, an itemisation of major cannabinoids and terpenes by weight with a leading zero below 1%, every major allergen contained and used in the process, any solvents used, the production date, and the Delaware Poison Control Center telephone number. Section 9.2.1 adds a codified 6 point (or 1/2 inch) minimum type size for all label text - previously attributed here to a Royal Supply design document - plus legibility, contrast, English and marketing-layer placement rules. Section 9.2.4.4 forbids modifying, recreating, stylizing or distorting the universal symbol in any way that changes its appearance or size. source ➞ In Effect

In effectPennsylvaniaDry leaf is exempt from the opacity requirement, and Pennsylvania never says light-resistant. 28 Pa. Code s 1151a.34(b)(3) reads 'Is opaque. This requirement does not apply to packages containing dry leaf.' This hub published opaque and light-resistant packaging as required with no exception and no citation, which over-specifies flower packaging at the customer's cost. Separately, the unauthorized-use warning at (d)(16) was published as 'carry a warning about unauthorized use'; the rule requires the warning to say that unauthorized use is unlawful and will subject the purchaser to criminal penalties. The four prohibitions at s 1151a.34(e) - no resemblance to trademarked food or beverage packaging, no artwork implying the package holds something else, no seal, flag, crest, coat of arms or other insignia implying government endorsement, and nothing that might make the package attractive to children - were absent from this page entirely and are now published. source ➞ In Effect

State-By-State Packaging Compliance Made Simple

The U.S. Cannabis Coverage Map

State Packaging & Labeling Guides

Alabama

Alaska

Arizona

Arkansas

California

Colorado

Connecticut

Delaware

Florida

Georgia

Hawaii

Illinois

Iowa

Kentucky

Louisiana

Maine

Maryland

Massachusetts

Michigan

Minnesota

Mississippi

Missouri

Montana

Nevada

New Hampshire

New Jersey

New Mexico

New York

North Dakota

Ohio

Oklahoma

Oregon

Pennsylvania

Rhode Island

South Dakota

Utah

Vermont

Virginia

Washington

West Virginia

Packaging Label Checker Beta

Check A Label Against Your State’s Rules

Upload Dieline

File Preview

Compliance Results

Compliance Audit Report

Want A Human ToReview Your Label?

Compare State Requirements

Packaging Rules & Pre-Approval

Colors

Shapes & Physical Forms

Characters & Imagery

Text & Words

Copycat / Brand Imitation

Environmental & Material Restrictions

Missouri

Nevada

Oregon

Pennsylvania

West Virginia

Washington

Maryland

Oklahoma

Montana

North Dakota

Florida

Maine

Kentucky

Agencies & Regulatory Updates

Alaska

Arizona

California

Colorado

Connecticut

Delaware

Illinois

Maine

State-By-State
Packaging Compliance
Made Simple

Want A Human To
Review Your Label?

Get Regulatory Updates
Before They Bite